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INTRODUCTION 
Suppurative arthritis in young pigs is generally caused 
by beta^hemolytic streptococci belonging to Lancefield's 
serological Group C {'^'26). The principal etiological 
agents have been reported to be Streptococcus zooepidemicus 
and Streptococcus equisimilis (78, 2^6), Collier (78) orig­
inally suggested the importance of S. equisimllis in young 
swine and his findings have been confirmed by others (330, 
375» ^71). Suppurative arthritis in young swine has also 
been produced by organisms found in Lancefield Groups D 
(lt^2) and L ((^78). 
The importance of the disease has been indicated by 
Collier (78), Helms (200)# Doty and Vorhies (H'i-) and 
Shuman and Wood (^26) «, Approzimately 50 per cent (236 of 
I8.93) of swin® streptococcal isolates from diagnostic 
laboratory cases were Group C organisms (^26)» Besides 
septicemia and suppurative arthritis in young pigs; 
8, equisimllis has been isolated frequently from the re­
productive tracts (195» 200) and mammary glands of sows 
(^89 178; 373) where it has been assoolated by soiss vet­
erinary practioners and diagnosticians with abortion 
and other forms of reproductive failure ( 114-) « However, 
definite proof that the organism is responsible for these 
disorders has not been reported (382, !+4'9) » Ko economic 
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surveys have been reported relative to losses attributed 
to Group C organisms, particularly S, equisimills. 
8. equisiaills produces septicemia and suppurative 
arthritis in s^ine from birth to six weeks of age (78, 
2^6), The infection is manifested primarily as an acute 
suppurative arthritis charaoteriied by an evaluated temper­
ature, pain, lameness and swelling of affected joints (381). 
Mortality is generally low but morbidity may reach 100 per 
cent in affected litters» 
The pathogenesis of the experimental disease induced 
in swine by S. equisimilis was characterized by Roberts 
si» (37'^'» 375, 376) « However, the pathogenesis of 8, 
equisimilis infections in the field are not completely 
understood» One assumption is that the organism may 
invade the baby pigs body by way of the umbilicus, foot 
and skin wounds or palatine tonsils (200). From the 
initial entry site, the organism is distributed heaa-
togenously to the areas where it is deposited and 
promotes suppurative arthritis. This mode of distribution 
suggests that humoral antibody with bactericidal activity 
could control sconomic losses caused by S» equisimilis» 
The proteinaceous, type-specific antigen of S, 
equisimilis appears similar in many respects to the 
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M»protein of Group A streptococci (246, 322, 378)« Because 
of the physiological similarity of the protelnaceous type-
specific antigen# it may be possible to utilize this organ­
ism as a model for studying M-protein-like material in an 
animal model with the ultimate goal of developing a safe 
and efficacious vaccine for human use. 
Killed ^hole cell baoterlns have been recommended for 
use In the control of beta hemolytic streptococcus infec­
tions in swine (195, 200), These reports suggested cura­
tive as well as preventive uses for the bacterins» Bao­
terlns prepeured from other Group C streptococci have been 
used to control mastitis in cattle (61, 107, ^ 55) and 
strangles in horses (22, 13^, 512)o Vaccinated animals 
remained relatively asymptomatic following field exposure 
or experimental challenge (24, 25e 511)» 
The purpose of this study was to eT&lu&ts liss-ansssnicity 
of So eoulsimilis. The primary objective was development 
of a vaccins capable of eliciting a protective response in 
swine. Secondary objectives were development of a aero-
logleal tool to measure the antibody response and further 
oharaoterizatlons of the antigens of S, eauisimllis. 
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REVIEW OF THE LITERATURE 
The word stroptocoooïis was used in the foï® strepto-
coeeos In 18?4 to degcribs a ssrtaln morphologleal phase 
of CoQoobaoterla septloa. the universal genus Into «hloh 
Billroth placed all miofo'bes (36), Rosenbach (1884) is 
credited with giving the first clear description of strep-» 
tococcus as a genus when he described chains of coeooid 
organisms in suppurative lesions In man. He named the 
orgarniam Streptoeoocus pyogenes (380), 
Subsequent to 1884; streptococci were isolated from a 
wide variety of lesions in man and animais, Heterogeneity 
of morphologic and biochemical activity was observed among 
these isolates. Attempts were made to identify and class­
ify the organisms on the basis of cell size and chain 
length (285)0 hemolytic action on blood agar (49; 4(55); 
fermentative activity in carbohydrates (8, 332s 473) end 
a combination of fermentative and hemolytic activity (30, 
213)0 First attempts at serologic classification of strep­
tococci were based on use of agglutination and precipita­
tion (183, 264, 273). 
The organisms are now classified into major groups on 
the basis of specific polysaccharide haptens, Further 
subdivisions are often made on the basis of other antigens 
that are polysaccharide, protein or a combination of both. 
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Certain physlologleal oharaoterlsties are also us@d for 
subdivision of the major groups9 
The original demonstration of serologically active, 
polysaccharide haptens in streptococci is attributed to 
Hitchcock (211) and Lancefield (26^, 265e 266)« Lanoefleld 
Is credited iflth most of the work because she Identified 
the group "C" substance, a specific polysaccharide for 
each group9 The serologleal grouping system bears her 
name. On the basis of specificity of the "C" substance» 
Lancefield originally classified ÏO6 strains of hemolytic 
streptococci into groups A, B, C, D and E (273)0 Over 
the years, serological groups P, G, E, Kg L, M, N, O9 ?» 
Qe Be S and T have been characterized (96). Two additional 
groups s U and V, have been proposed (220, 4-72) « The "C" 
substance is usually an integral part of the cell wall 
firmly bound to the muwopoptlde layer by dosaient bonds 
(384), The group specific determinant of groups D, 
N and possibly Q differ from those of other Lancefield 
groups in that they are glycerol-teiohoic acids, 
Ïndi-idiïâl Group arid xyps-Spscific Antigens 
Group A 
Over twenty different antigenic materials have been 
detected in concentrated, supernatant fluids of cultures 
of Group A streptococci by immunoeleotrophoretlo analysis 
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(173» 192), Some extracellular products are enzymes 
that facilitate invasion of organisms,, such as hyaluronidase 
and streptokinase (l4o@ 476). Other ©stracellular products 
include exotoxins such as Streptolysin 0 (189)» Streptolysin 
S (173) and diphosphopyridlne nucleotidase (60)» The role 
of all extracellular products and compounds will be dis­
cussed later. 
The Group A carbohydrate is an integral part of the 
cell wall (211, 3059 309)9 has a molecular weight of approx­
imately 10B000 deltons (149) and is composed of 38 moles of 
L-rhamnose and I7 moles of W-acetyl-glucosamine (253» 4^1), 
Terminal beta-N-acetyl-glucosamine residues are the immuno­
dominant determinants of specificity (303)» The polysac­
charide is linked to the aucopeptids by bridges of phosphate 
containing glycerol-rhamnoside (169# 256). In certain 
strains 9 known as Group A-variant streptococci 9 terminal 
amino sugar residues are absente Such strains have been 
used to establish that antigenic specificity is dependent 
upon the L-rhamnose moiety (202, 203, 310, 311, 365)® 
The cell wall peptidoglycan of Group A consists of 
repeating units of N=acetyl=gluoos@mln@ (NAG) and N-acetyl-
muramic acid (NAM) which are cross-linked by tetrapeptides 
(L-alanyl-D-glutanyl-L-lysyl-D-alanine) through the oarboxyl 
group of muramio acid (llg, 257), Approximately 10 per cent 
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of the tetrapeptldes in the NAG-NAM peptide "backbone are 
not cross-linked and have an additional D-alanlne ^ hich 
converts them to antigenic free-hemglng pentapeptides (17). 
With this type of linkage, the free and non-cross-linked 
pentapeptide acts as the primary antigen while the cross-
linked tetrapeptlde acts as a weak antigen. These antigens 
have been used occasionally in classification of certain 
Group A strains (84, 299, 378)o 
The outer component of the Group A streptococcal cell 
wall is a protein layer that contains three major antigens 
known as M, T and R proteins (312)® At least two minor anti­
gens, "M-associated protein" (MAP) (4-98) and opacity factor 
(OP) (180) are also located in the outer layer. The typing 
antigens T and R have been used in epidemologlcal studies 
to trace the spread of an outbreak while MAP and OF have 
been used primerily as aids in typing (272, jOi, 482, 49?). 
At the present tiise, no biological significance has been 
attached to T, R, MAP and OP antigens (384), 
The earliest method for serologically typing strepto­
cocci within Lanoefield®s groups was on the basis of M» 
antigen, a substance used in Griffith's original method 
of serotyplng Group A streptococci (183)» He established 
27 types by means of agglutination. Three of the original 
27 types were found later to belong in Group C and one 
was reclassified in Group G (422), At present^ 60 types 
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have been identified %ithln Group A on the basis of K-
antigens (174). Some strains lack or have lost the anti­
gen, some have two different M»antlgens (384) and others 
carry cross-protective determinants (149, 298» 499), 
These tyi^-speclflc substances are sensitive to activity 
of proteolytic enzymes (1?6)» In cultures of streptococcal 
protoplasts or L-forms, M=protein accumulates in the medium, 
indicating that, although the end product In the Intact 
cell is deposited In serologically active form on the cell 
%all and bound there, this is not the major site of its 
production (72, 186), Biosynthesis of M-protein, as studied 
by use of non-'^oliferatlng streptococci, requires peptides, 
free amino acids and glucose (259)« 
M-protelm antigen was demonstrated in or on the cell 
wall of organisms groim in medium containing fluorescein-
labeled antlwwuj (181,462)« The surface location of type 
antigens was indicated by lemunoelectron aicroscopy using 
ferritin labeled antibody (216), Similar substances have 
been found on the surfaces of streptococci of other Lance-
field groups (298, $12), 
Although several methods have been utilised for extrac­
tion of M-antigen from cells, Lancefleld's original hot 
acid extraction method is the most commonly used (264), 
Other methods have included cashing %lth buffered saline 
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(198)» alkaline eztraotlon (151» 1$2), sonlo oscillation 
(35, 66, 324), ©nzymtic degradation (27, 88, 11?) and lysis 
by phage (233» 25^» 255» 296), Crude H=prot@ln obtained 
by use of any of the methods has been purified by a variety 
of protein purification methods including ammonium sulfate 
precipitation (278), zone electrophoresis in starch (357)e 
precipitation at rediseed pH (209), density gradient coluan 
electrophoresis (4lO), ion-exchange or filtration chroma­
tography (223) and combinations of one or more of these 
methods (147, 150, 331). 
M-protein has been shorn to possess the following 
general properties: it is antigenic (268)g has a molecular 
weight of 40,000 daltons (268), belongs to the class of 
alcohol soluble proteins (268), la destroyed by proteolytic 
enzymes (276), resists boiling for a short time at pH 2 
and pH 10 (152(1 z64), has an isoeieotrio pE value of about 
5,3 (174), Is commonly associated with other protein antigens 
(312)9 has a multiple molecular structure (150) and as 
indicated above Is bound to the cell wall (72, 186). 
Antibodies against two different non-type-speciflc antigens 
have been detected serologically in highly purified 1-
preparations» These antigens have been identified as the 
MAP and OF antigens which were mentioned previously. Their 
presence or absence dep@ads upon the type of oztractlon 
(27, 88). 
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Grottp B 
The Group B carbohydrate Is located in the cell wall 
(82» 279) and is composed of 50 per cent L-rhamnose, 9 to 
11 per cent D-galactose, and 11 to 12 per cent N-mcetyl-
glucosamine (89, 508). L-rhamnose was shown by quantita­
tive precipitin inhibition, to be the immunodominant anti­
genic determinant Cl-Sl)» Strains of Group B have been 
found that lack the group antigen, although they did 
contain type-specific antigens (20?)« Cross reactions 
have been observed in precipitin tests between Group B, 
Group C and Group A variant streptococci. All three have 
L-rhamnose as an antigenic determinant (89)« 
Cell walls of Group B organisms also contain other 
polysaccharides that contain type-specific determinants 
(267), On the basis of preoipitin anâ mouge pgoteetlon 
tests (27^)» the majority of Group B streptococci were 
originally placed into 4 types, lA, IB, II and IV® A 
fifth type, IC, has been added recently (500» 501)« 
Stableforth ('^•51) reported that by use of precipitin 
and agglutinin absorption, 16 types of Group B streptococci 
could bs identified. Pattison et al» (3^8, 3^9) found 
two protein antigens, X and Y, in the cell wall. He 
demonstrated that all I6 types could be placed into three 
serological types, I, II and III, on the basis of 4 
polysaccharid© and 2 protein antigens. 
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The ï antigen was determined to be almost identical 
to the R antigen that is found in Groups A, C, G and L and 
it was redesignated E antigen (272). This antigen has 
been shoim to be an active component in cross reactions 
among all Lancefield groups possessing it (298)9 
Type-specific antigen ÎA is a polysaccharide composed 
primarily of 69 per cant B^galacWse and 25 per cent I» . 
acetyl-glucosamine (500). The inunodeterminant group has 
been shoim to be more complez than a monosaccharid© » probably 
N»ac@tyl«galactosamine in combination with another sugar 
moiety. 
Type IC is also a polysaccharide that contains most 
of the components found in Type lA polysaccharide in 
addition to a protein with two determinants that differ 
in susceptibility to trypsin and pepsin. This protein 
has been compared to the H-antlgem of Group A (SOû). 
Type II strains have "been found to produce 2 type-
specific antigens @£tracta»le with oold triculcrcac@tis 
acid, one of ^ hich was estraotable with hot add (279) « 
The terminal iomunodeterminant group of one antigen wag 
shown to be beta linked D-galactose (157) and sialic acid 
has been suggested as the other antigenic determinant (267)0 
Type III antigen was characterized by hydrolysis and 
chromatography and by nitrogen, phosphorus, amino acid and 
carbohydrate content, It was shown to be a polysaccharide 
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composed of 38.9 per cent galactose, 22.8 per cent N-acetjrl» 
glucosamine, 17,8 per cent glucose, 3,1 per cent uronlc acid 
and less than 0,1 per cent amino acids. Glucuronic acid 
appears to be one of the immunodominant components of this 
antigen (38?)« 
Group C 
, Organisms included in Ggoup C have been divided into 
five main species on the basis of biochemical characterise 
tics J So equia S, zooepldemlcua. S® dyagalactiae » S, canis 
and S. equisimilis (322)« Some Group C strains possess 
a hyaluronic acid capsule and several other extracellular 
substances similar to those found in Group Â (238, 253)@ 
The antigenic structure and cellular and colony morphology 
of 8. equlsimilis are similar to those of S, pyogenes 
(96, 38*^). 
The Group C carbohydrate is located in the cell call 
(258) and is composed of 42 per cent L-rhaiiBoss, 5 P@r cent 
H'-aeetyl-glucosamine and 3»9 per e©nt H®aô®tyi"gâlâêtôsaaine. 
The terminal antigenic determinant was shown by quantita­
tive precipitin inhibition to be H=acetyl«galactoBamin® 
(256). Serological reactions between antigens of Group G 
organisas and Group A antibodies are based on the common 
L-rhasnose backbone (4^92) » 
The composition and location of typ8«»sp©©lfic antig@as 
in Group C organisms differ among the Individual species0 
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All known tjp@-speclfio antigens are protein in nature 
as originally indicated by Lancefleld in her work with 
Griffith's type antigens (258)« The protein antigen of 
8. ©quialiallls is found at or near the surface of the cell 
similar to the type-apeciflo protein antigen of Group A 
(308, 378). 
So equl has 5 serological type-speoifie protein anti­
gens located in the capsule based on agglutination. However, 
8 types have been described based on precipitin-atosorption 
(25» 322). Bazeley (22, 23) has characterized these anti-
gèns serologically and biochemically. Only one type of 
protective antigen has been found. It was located in the 
capsules of very young cells. No information is available 
on terminal antigenic determinants, 
8, dysgalactlae has at least three type-specific protein 
antigens that are located In the cell %all (96) and the 
strain isolated from lambs may be another type (38). No 
chemical analysis of eompositidn has been reported. 
Eight different type<»specifiG antigens were demon­
strated in S. zooepidemicus by means of preclpitin-absorp-
tlon tests (322). 
The numbers of types within 8. equisimllis have varied 
with the investigator and the typing method used. Siaaons 
and Keogh (^3^) classified I65 human C (S. Qguisiailis) 
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strains into 5 types based, on slide agglutination and 
bioohemioal aetlvities. The ehemioal nature of these pro» 
te in antigens ms not determined « Bakshi and Singh (I3, 
14) divided this species into 4 types on the basis of 
preei pi tin-absorption» The antigens were determined to "be 
protein although the determinants were not Investigated, 
Evans ( 138 )s using carbohydrate fezaentàtlon and agglutina­
tion, demonstrated eight serological types among human @md 
animal isolates of §«, eauisimilis. She stated that these 
antigens were |s>otein in nature. Khan and Ross (246) class­
ified 62 of 64 swine isolates into 4 serological types 
utilizing precipltln-absorption. They demonstrated cross-
reactions between S® ©qui simili s type IV and Group L, 
Group D 
The group-speclfio antigenic determinant has been 
identified as a glycerol-teiohoic acid that may be a con­
stituent of the cytoplasmic membrane or the cytoplasm (495) 
or it may exist in the periplasmic space. It is not a con­
stituent of the cell wall (225® 379, 423, 439) and It is 
absent from protoplaafcs @md L-forms (204)= Serological 
specificity appears to be determined by the substituted 
sugar units kojlblose and kojitriose (53)= Barber et al. 
(16) have disputed the glycerol-telcholc acid concept and 
claim the determinant antigen is a nuclesprotein which 
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could be extracted from the whole cells with sodium 
desosycholate. The Group D antigen is similar to the 
Group N antigen and cross reacts with antiserum against it 
(131, 353, 416). 
The type-speeific antigens of Group D streptococci are 
located in the cell wall (128)« Sharpe and Shattock examined 
353 Group D strains and were able to establish 2^ distinct 
types by agglutination and precipitin tests (418). Types 
25 to 39 were added a little later (378)® Type I antigen 
appears to have D»glucose and N-acetyl-glucosamine as the 
antigenic determinants (39@ 40)b 
The Group D streptococci are separated into at least 
five species on the basis of physiological characteristics? 
S® auis. 8, eauinus= bovis. S, faecium and S, faeoalls 
(96, 373)• These species contain varying numbers of type-
spcûiriû «iltlg&jrljS that ®5r® polysBoohearlde in nature and 
generally contain N-acQtyl-glucosaHine (124g 128)» 
Ss suis has been demonstrated to contain sylcss in the 
group antigen and only one serotype has been described (129) # 
Type«sp®clflclty is associated with a capsular polysaccharide 
that contains D-gluoose, N-acetyl-glucosmaine and N-aoetyl-
galactosamine, 
Se bovis contains at least 12 serological types (231; 
317, 420) and possibly as many as 32 (96), The type-specific 
polysaccharide is associated with the capsule in all types, 
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except 5» In which it is a cell wall component. The capsule 
contains 22 per cent galacturonic acid, 18 per cent L-rham-
nose, D-galactose and D-glucose (231). Type II antigen has 
been demonstrated to contain 31 per cent N-acetyl-glucosamine. 
Quantitative precipitin inhibition tests indicated» however g 
this is not the antigenic determinant. Cross type reactions 
occur with other streptococci of Group A (232) and Groups 
E and N (356). 
Nineteen different serological types of 8. faecium have 
been described (20)« The antigens identified appear to be 
similar in composition to the 8. faecalis polysaccharide, 
although the exact composition and determinants are not known. 
The type-specific antigens are located in the cell wall (128), 
Eleven serotypes have been established within S. faecalis 
(126, 4-96) and the antigens appear to be located in the cell 
wall ({'21) » Type I antigen contains 22 to 30 per cent 
L-rhamnose, li*- to l6 per cent D-glucose, 6 per cent N-acetyl-
galactosamine and 6 per cent M-acetyl-glucosamine» D-glucose 
and N-acetyl-glucosamine, alpha linked to L-rhamnose, 
have been established by quantitative precipitin inhibi­
tion to be the antigenic determinants. The other antigens 
are felt to contain similar polysaccharides» Type III 
antigen contains at least two antigens; one is a neutral 
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pol^sacoharià® and the other is a negatively charged poly-
saccheride (503)• The Qntigonlo dstsrminant has not 'been 
identified# 
Cellmlar disruption of 8» ©quinus is required to 
demonstrate the group antigen (162, #3), Little informa­
tion is available on the nature of the type-speoifi© anti­
gen. 
Group E 
xh# Gx'oup E carbohydrate is located in the cell wall 
(323» 351» 3529 #1) and is composed of per cent L-rham-
nose, 20 per cent D-glucose and 2 per cent N-acetyl-glu-
cosamin® (437)« Terminally located beta-D-glucosyl residues 
(#7) have been shown to be the immunodominant antigenic 
determinant» This group has been shorn, to cross react with 
Groups ? and U even though ea@h greup has its own gpeclfio 
antigen (104^, 426, #2), 
The type-specific antigenic components are polysacchar­
ides that are located in the cell wall (323)® Five sero­
logical types, I to V, as well as several untypable strains 
have been identified. These antigens contain L-rhannose 
and D-glucose in addition to components of the group anti­
gen (#7) « This suggests that only relatively minor chem­
ical differences exist between the type-specific antigens 
and the group antigens. Some of the type antigens have 
also been sho^n to contain D-galactoss; however, the 
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composition and antigenic determinants are unknown. In 
recent work, the validity of types I and III was questioned 
(513). 
Group F 
The Group P carbohydrate is located in the cell wall 
(82, 34'3) and is composed of 35 to ^f-O per cent L-rhamnose, 
12 to 15 per cent D-glucose, 2 per cent N-acetyl-glucosamine» 
M-acetyl-galactosamine and a very small amount of galactose 
(130, 131)• The terminal antigenic determinant appears to 
be a tetrasaccharide composed of two units of 3.0°S-D-
glucopyranosyl-N-acetyl-galactosamine, which is glycosldl-
cally linked to an L-rhamnose backbone. This group demon­
strates occasional cross-reactions, attributed to a rhamnose 
moiety, with strains belonging to Groups A» B, C, G, L and 
T (130). Strains have been Identified that contain type-
specific antigens but which do not contain the group 
carbohydrate (199)® 
Five serological types, I to V, have been demonstrated 
within this group by use of precipitating and/or agglutina­
ting procedures (^1, 319^ 320. 3^3p 502). The type-specific 
antigens are polysaccharides that are located close to the 
surface of the cell (506). Some strains have mora than 
one type=specifio antigenic determinant. 
Type I antigen contains D-glucose, L-rhamnose» D-
galactose, mannose and N-acetyl-galactosamlne (318, 502), 
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N-ac0tyl-galactosamine has been shomi by quantitative 
precipitin inhibition to be the antigenic determinant« 
This antigen cross reacts with antiserum against Group G 
strains (506), 
Type III antigen has been located in streptococcal 
Groups C, P and L (505)» It is a polysaccharide which 
contains D-glueose» L-rhaanose 9 N«aô©tyl-glucosaîsîne and 
N-acetyl»galaetosamine (502), The dlsaccharide, N=acetyl= 
glucosamine and N<-acetyl«galactosamine has been demonstrated 
to be the antigenic determinant (505)® This antigen cross 
reacts mlth antiserum against strains in Group C (3^3) and 
Group L (504). 
Type IV antigen has been demonstrated to be a poly­
saccharide similar in composition to the other types® The 
antigenic determinant appears to be a beta-glucosidlc 
moiety (306)9 
Type V antigen is a polysaccharide that has D-gluoose 
as the terminal antigenic determinant. The glucose is ad­
jacent to a galactose or rhamnose moiety (506)» 
The location of the Group F antigen and the type III 
antigen was evaluated using ferrltln-labeled antiserum and 
immunoelectron microscopy# Findings demonstrated that 
type III antigen was on the outermost layer of the strep­
tococcal cell and that It appeared to be capsule like. The 
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group antigen was located deeper in the streptocoooal 
oapsule (216)» 
Group G 
The Group G carbohydrate is located in the cell wall 
(69) and Is composed of 39 per cent L-rhasnnos© b 19 per 
cent N»aoetyl«galactosaffllne and 22 per cent D«galactos@ 
(378). L=rhaianos© is the terminal antlgenle determinant 
and as stated previously; it is the same determinant that 
gives Group B its specificity, although their spatial 
configuration gives these two groups slightly different 
specificities (89, 90)» The tw groups do cross react 
in the precipitin test# In addition Gzoup G csoss seacts 
with Group A (434), 
There are two major types of organisms comprising 
this group, "minute" and large. The "minute" strains are 
all aii-bisenically similar to the "minute" type I strains 
of Group P. Chemical analysis Indicated the type-specifle 
antigen is composed of a complez polysaooharlde although 
the terminal active component has not been Identified. 
The large colony type has been separated into three types, 
15 II and III9 by agglutinations The chemical composition 
of type-specific antigens of the large colony type has not 
been determined, although, they are thought to be a complex 
polysaccharide (41, 96). 
21 
Group G streptococci often possess a full complement 
of Group A extracellular products and one strain has been 
demonstrated to possess an K-proteln antigen (298, 300)s 
Because Groups A, C and G share some common antigenic 
components, fluorescent antibody typing techniques are 
useless unless absorbed serums are used* The cross reac­
tivity is attributed to the L-rhesmose backbone in the 
cell walls of all three groups (256), 
Group H 
The Group H carbohydrate is located in the cell wall 
(440) and is composed of L-rhamnose@ D-glucose, D-galactose 
and fucosamine (377)« The terminal antigenic determinant 
is probably L-rhamnose although, a glyerol-teiohoic acid 
has also been suggested as the determinant (^85)« 
Antigens conferring type-specificity appear to be 
located in the cell wall (141; 489)* The types are desig­
nated 19 II, III, c and de Types c and d have filamentous 
processes that are destroyed by proteolytic enzymes (263)» 
The antigenic determinants have not been characterized. 
Type I antigen has been shown to be a glycerol-telohoic 
acid located in the cell membrane « This has been suggested 
as the group antigen by one investigator (485)* Type II 
antigen contains D-galactose and N=>acetyl=galactosamine as 
the antigenic determinant, Type III antigen has been shown 
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to cross react with Group E antiserum (378). Some strains 
have more than one type-specific antigen. 
Group K 
The Group K carbohydrate Is located in the cell wall 
(377, 437) and is composed of L-rhamnose, D-lactose, 
D«glucose, N-acetyl-glucosaaine and N-acetyl-galactosamine, 
The terminal antigenic determinant is L-rhamnose, This 
group cross reacts strongly with Group F type III anti­
serum (2^9), 
The type-specific antigenic determinants are poly­
saccharide in nature are located in the cell wall. Based 
on precipitin-absorption tests, serological types I, II 
and I/II have been described (456). The chemical compo­
sition has been shown to be D-galactose, D-glucose, 
L-rhamnose and 0-B-D-galactopyranosyl-( 1-6)-D-galactose; 
The latter compound has been reported to be the antigenic 
determinant for type II, The third type is apparently a 
combination of the other types. 
Filamentous surface processes that are susceptible 
to trypsin have been identified in this group (1/0, 263). 
Although these antigens have not been fully elucidated, 
it is thought that they are not related to type-specificity» 
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Group L 
The Group L carbohydrate is located in the cell wall 
(238) and is composed of N-acetyl-galactosamine, D-galactose, 
L-rhamnose, N-acetyl-glucosamine, alanine, glutamic acid, 
lysine and muramic acid {il40>. The antigenic determinant 
consists of two components, L-rhamnose and B-N-acetyl-
glucosamine. Group L antigen cross reacts with antiserum 
against Group A (221), Group C and G ( 281), Khan and Ross 
(246) reported cross reactions between S, eguisimilis 
serotype IV antiserum and acid-extracted Group L antigen. 
The group antigen is partially acid labile. 
Two type-specific antigens have been suggested. One 
antigen is trypsin sensitive and the other is trypsin 
labile. It appears that the trypsin labile antigen is 
related to the M»protein of Group A streptococci (238), 
Group M 
The Group M carbohydrate is located in the cell #all 
(377) and is composed of L-rhamnose « D-glucose, D-galactose, 
alanine, glutamic acid, lysine, aspartlc acid, N-acetyl-
glucosamine and murajnlc acid (3??; 4^0) * Three biotypes 
have been identified by physiological and serological 
tests (436). Biotype I contains a "group" antigen that 
is heat stable and insensitive to trypsin. Biotype III 
contains a "group" antigen that is heat labile and sensitive 
to pepsin. Biotype II has a combination of both of these 
antigens. No type-specific antigens have been described, 
although Biotyp® I strains cross-react with antiserum 
against Group K and this would probably be due to a common 
component. 
Group M 
The specific antigenic determinant of Group N has been 
identified as a teichoic acid that is located in the cyto­
plasmic membrane (12?* 442), D=salactoss phosphate has been 
shown by precipitin tests to be the antigenic determinant. 
The group antigen cross reacts with antiserum against 
Group D strains because of common antigenic determinants. 
Cross reactions with Group Q have not been reported, al­
though the latter group also has the same general type of 
antigenic determinant. 
The type-specific antigens, A and B, are located in 
the cell wall and chemical analysis indicated they consist 
of a mucopeptlde backbone with L-rhamnose attached to side 
chains. Attached to the L-rhamnose are the serologically 
specific N=-ac8tyl-galacto3Sinine and N-acetyl-gluOOsaslnes 
Antigen A contains L-rhamnose, muramic acid, N-acetyl-
glucosamine, N-acetyl^galactosamine» lysine, alanine, 
glutamic acid and aspartlc acid (96), 
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Group 0 
The Group 0 carbohydrate is located in the cell wall 
(325. 326) and is composed of D-gluGOse, D-galaotose, 
N-acetyl->glucosamin@ and N-acetjl-galaotosamins but it does 
not contain L-rhamnose (377)• The antigenic determinant 
appears to be N~acetyl-b-D-glucosamln®o Extraction of the 
group polysaccharide by Puller's formamide procedure (I60) 
destroys its specificity (42). Because both Group A and Group 
L contain a similar antigenic determinants cross reactions 
occur between them. 
Group 0 streptococci have been separated into types 
I and II (325), Type I antigen, a cell wall protein, may 
be separated into three fractions, each possessing serolog­
ical specificity» This protein is considered to be a com­
plex structure of undetermined chemical composition. 
Type II antigen is a nudeoprctsin of undetermined cell 
location. These antigens are eztractable with hot acid 
and possess properties which may be used to separate them 
from the streptococcal protein antigens M, T, E, MAP and 
OP of other Lancefleld groups. 
Group P 
The Group P carbohydrate is located in the cell wall 
(44o) and Is composed of alanine, glutamic acid» lysine, 
N-acetyl-glucosamin@8 muramlc acid, L-rhamnosej D-galactose 
and D-glucose« 
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Recent reports have directly related Group P to the 
newly proposed Group U (104, 424), It was suggested that 
strains now assigned to Group P simply lacked group antigen 
and the observed precipitin reactions were due to a type-
specific antigen, a situation similar to the z antigens 
found in Group P. Strains assigned to Group U contain the 
Group P carbohydrate as well as another type-specific anti­
gen (104). 
Group Q 
The Group Q carbohydrate is located in the cell wall 
and is composed of L-rh&mnose, D-glucose, D-galactose and 
N-acètyl-galactosamine (185, 442), The antigenic determl-
nantg L-rhamnose, has not been demonstrated in all strains® 
Most strains also contain an antigen similar to the teichoic 
acid of Group D and Group N, located between the cell wall 
and the protoplasmic membrane, which occasionally may be 
responsible for cross reactions among these groups (337? 
338). 
Located in the cell wall are two type-specific anti­
gens. Or and Qw. that were identified by precipitin absorp­
tion (337)» The antigen designated Qr forms a single band 
detectable by immunodiffusion which is destroyed by treating 
the antigen with periodate. The cell wall has been shown 
to contain several carbohydrates one of ^hich must be the 
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antigenic determinant. The Qw antigen appears to lack 
the group carbohydrate but possesses a type-specific antl« 
gen of unknown chemical composition. 
Group R 
The Group R carbohydrate is located in the cell wall 
(377) and is composed of D-glucose, D-galactose, L-rhamnose 
and N=acetyl=glucosaiaine. D-galactose in the terminal alpha 
linkage was shown by precipitin absorption to be the antl» 
genie determinant (437), D-glucose also plays a role in 
specificity but it is located subterminally and only plays 
a minor role. Some investigators have suggested that the 
group antigen is acid labile (355)® 
Sis serologically active forms have been reported 
(442). Sonic treatment releases antigen forms 4, 5 and 6, 
The chemical composition and antigenic determinants have 
not been identified. 
Group S 
The Group S carbohydrate is located in the cell wail 
(440) and is composed of alanine» glutamic acid, lysine, 
N-acetyl-glucosamines D-galactose» L-rhamnose and N-acetyl-
galactosamine (377). The antigenic determinant has not 
been identified but the group cross reacts with Group T, 
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Group T 
The Group T carbohydrate is located in the cell wall 
and is composed of 23 per cent L-rhamnose, 7 per cent 
D-glucose, 26 per cent D-galactose» 16 per cent N-acetyl-
glucosamlne smd 3 per cent N-acetyl«galactosamine (437), 
N-acetyl-glucosamine and N-acetyl-galactosamine have been 
suggested as forming the antigenic determinant. This 
group cross reacts with antiserum against Group S, 
No information has been reported in relation to 
type-specific antigens. 
Group U 
The cell U carbohydrate appears to be located in 
the cell wall since the antigen is extïactable with formamlde, 
although its chemical composition has not been determined 
(10%). The group sntigsn Is net sztractabls by tho ccnvsn-
tional hot acid procedure, suggesting that it is acid 
labile. The Group U antigen cross reacts with antiserum 
against Group E and Group P (104, 431)e 
de Moor and Thai (104) have suggested that Group P 
and Group U streptococci belong to one serological group. 
The Group P strains, they felt, lacked the group antigen 
but contained some common type-specific antigenic 
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determinants. Recent work by Shuman and Nord has 
confirmed the validity of both Group ? and Gs'oup U, Their 
results were obtained by precipitin absorption teats. 
Group V 
The Group V carbohydrate appears to be located in 
the cell wall since the antigenic component is ©straetable 
with hot acid and formamide, although its chemical com­
position has not been determined (220). The group does 
not cross react with antigens or antiserum of other 
Lancefield groups. 
No information has been reported in relation to type-
specific antigens. 
Non-grcupable strains 
Several strains of beta hemolytic streptococci have 
been isolar-ed from man and animals that either fail to 
possess a known group antigen or have one that has not 
been clearly defined. As more and more of these strains 
are characterized and then grouped, several new Lance­
field groups will be added to the present list. 
Some of the strains appear to contain antigenic com­
ponents that cross react with antibodies against type-
specific antigens in groups E (323) and F (505)» The 
reasons for this have not been investigated. 
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Other Antigens of Streptococci 
In the development of en understanding of the anti­
body response to streptococcal infection, initial emphasis 
^as placed on evaluation of antibodies which protected the 
host from disease. Early reports were often contradictory 
or inconclusive because little was knomi about the complex 
antigenic composition ef streptooooeal cells. Lancefield 
(264) and Griffith (183) clarified most of the confusion 
when they separated streptococci into groups and serotypes, 
The serological response to a given streptococcal 
antigen is quite variable. Within any population, some 
individuals may not produce any detectable antibodies 
while others produce a variety of group, type and strain 
specific antibodies» As previously noted,over 20 different 
precipitating antigens have been associated with strepto­
cocci* In the following discussion, antigens of strepto­
cocci other thm% group and type-specific antigens el11 be 
reviewed. 
Capsular hyaluronic acid 
The hyaluronic add of the capsule is not antigenic 
because chemically it is closely related to the hyaluronic 
acids found in animal tissue (304), 
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The cell wall of most streptoooeol contains a variety 
^ components, some of which are proteinaceous in ooiapo-
sition and others that are basically carbohydrate in nature. 
The cell wall appears to be composed of three layers which 
are either separate layers or intercalated (256). The 
sain components of the cell wall are protein (391), carbo­
hydrate (275) and muoopeptid© (385)® Covalent bonds have 
been found between the mueopeptlde and carbohydrate layers 
(384) and their existence between the protein layer and 
mueopeptlde layer has been speculated. 
Antigenicity of the protein and carbohydrate antigens 
has been covered in the first section. The mueopeptlde 
component has been shown to be antigenic in rabbits as 
evaluated by quantitative precipitin reactions (4l4). Factors 
that suggest that this is a specific Inmunological reaction 
includes antibody concentration Increases following specific 
iîssunisswioîi of rsbbits >?ith mueopeptlde (3)e reactions Bze 
observed only with serum fractions containing IgG Immuno­
globulins (3); specificity of the reaction was deaeastrated 
by cross-absorption with heterologous antigens and anti­
serum (1) and protein eluted from mucopeptide-antibody 
complexes was shown to be an IgG globulin by immunodiffusion 
and issiunoelectrophorasie (3^0) « Earakawa and Krause (236) 
demonstrated that the mueopeptlde component has two 
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antigenic determinants 5 a peptldlc fraction and a hexosamlne 
polymer. Antigenicity of the hesosamlne polymer was demon­
strated by blocking the precipitin reaction %lth a hesos-
amlne rich dlalyzable fraction of an enzymatic digest of 
cell walls (237). 
Mucopeptide has a pronounced capacity to act as an 
adjuvant and thus enhance antibody formation when adialnis= 
tered with other antigens {21^), 
Polyglycerophosphate 
Glycerol-teichoic acid @ which makes up approximately 
1 per cent of the dry wight of a cell, has been shown to 
be located near the cell wall (384), It is the antigenic 
determinant for Groups D and N. This substance precipi­
tates with some antiserums to Group â streptococci (307), 
Glycerol-teichoic acid has also been found in other Gram 
positive bacteria (392), 
Protoplast membrane 
The protoplast membrane is located beneath the cell 
wall and encloses the cytoplasm. It is composed of 72 
per cent protein, 26 per cent lipid and 2 per cent carbo­
hydrate (156)0 Immunization of rabbits with Group A cell 
membranes results in production of specific serum antibody 
detectable in quantitative precipitin tests. These anti­
bodies have the ability to cause rapid rejection of skin 
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allografts In guinea pigs suggesting that the antigens 
may play a role In the Induction of altered tissue reac­
tivity in the mammalian host (368), This antigen may also 
contribute to some cross reactions between Groups C, A 
and G, 
Intracellular streptococcal components 
The cytoplasm eentalns a complet of protein, nucleo­
tides » nucleic acids and enzymes. At least eleven distinct 
components (201) have been distinguished eleotrophoretloally, 
These intracellular antigenic substances have not been studied 
as Mell as the cell wall or extracellular products, 
Lanceflsld (270) demonstrated that the nucleoprotein 
of streptococci had a high degree of antigenic heterogeneity. 
Antiserum against nucleoproteins from hemolytic streptococci 
cross-reacts with nucleoproteins of non-hemolytic strepto­
cocci e pneumococcl and staphylococci (302)0 
Beta-glucuronidase is produced "by strains of strepto-
cocel belonging to Groups A, B, C, G, 2 and L (^57)» This 
enzyme is apparently non-antigenic in its natural state 
since antibodies against it have not been detected in 
serum of patients convalescing from streptococcal infections 
(384). 
Lipoprotelnass has been sho%n to be produced In an 
inverse proportion to the production of M-proteln (248, 260), 
The enzyme resembles Streptolysin S in that it may be eluted 
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from cells with the aid of serum. Antibodies against 
this enzsrme inhibit its enzymatic activity and they have 
also been found in human serums. 
Sonic disruption releases an Intracellular hemolysin 
that resembles Streptolysin S, The two substances can be 
distinguished by their differential susceptibility to 
potassium and sodium ions. The intracellular hemolysin 
is antigenic and specific antibodies to this enzyme are 
occasionally found in convalescent humans (411, 412, 413, 
419). 
Virulence Factors 
Virulence* the disease-producing capacity of a micro­
organism, is attributed to three factorsi infectivity, 
invasiveness and toxigenlclty, Infectivity depends on a 
OOuipXSjT of pX^OpoX'tiOS txl»t GZlSblG tllG miOjTOOX^gâTlioIu tO 
establish an initial seat of infection within the host 
by evading or overcoming the host's looal defense mechanisms^ 
Invasiveness is the ability of the microorganism to leave 
the initial site of infection and grow in other tissues « 
Tosigenicity is the ability to produce toxic or poisonous 
substances that are capable of damaging the host tissue. 
Virulence of streptococci has been studied chiefly 
in relation to Group A strains and the following informa­
tion refers mainly to this group. Virulence of streptococci 
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has not been attributed to any single cellular component or 
product but rather to a combination of physical and biochem­
ical properties. H-protein and the capsular polysaccfnaride 
have been the most commonly identified major virulence factors 
(91, 125» 1^5» 206, 261, 268, Wo). Other cellular components 
or products that may be associated with virulence includes 
hyeluronidase, leukotezlc and leukocidal products» ribonuclease 
and deozyribonuclease and proteinase. It has been suggested 
that other factors still not known are essential to the develo» 
ment of virulence of streptococci for different animal species 
(28, 29). 
M-protein 
M-proteln is distributed on the surface of the cell in 
the form of a capsule-like material (462), not blocked by the 
hyaluronate envelope of Group A streptococci (l4^)e Purther-
more, anti-M-antibody is protective, indicating that the 
M-antigen is directly involved in streptococcal virulences in­
deed, both the hyaluronate capsule end the M-protein are anti­
phagocytic (l4^). M-proteln prevents intracellular destruction 
of streptooooci unless the cells are coated with type-specific 
antibody (I68), Immunity to Group A streptococcal infections 
is directly related to the presence of type-specific antibody 
(26, 153» 3.5^6 294, ^58)0 Virulent M=protein containing 
strains of S, pyogenes have been shown to adhere to human 
pharyngeal cells ^  vitro, while avirulent M-negative strains 
only adhered feebly (122b). 
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Hyalttgonle add 
Hyaluronic acid, a mucopolysaccharide, has been sug­
gested as a virulence factor in Group A, Group C and 
possibly Group 6 (239). Evidence that hyaluronic acid is 
associated with Tirulenc® has been demonstrated by its en­
hancing effect on invasiveness amd its interference with anti-
phagocytosis, Hyaluronic acid was shorn to facilitate in= 
vasiveness in aerosol infections in mice (91, 222). Mice in­
fected with strains denuded of hyaluronic acid resisted in­
fection while control mice infected with the same strain with 
an intact hyaluronic acid capsule became Infected, This 
function was felt to be independent of M-protein« ïh® exact 
mechanisms are unknown, although it has been suggested that 
hyaluronic acid aids the organism in establishing a foot-hold 
in the mucosa of the naso-pharynz, possibly because of its 
chemical similarity to cement substances of the tissue (17'+)» 
It has also been shown to participate as an antiphago­
cytic factor, A correlation between the presence of a large 
capsule among various streptococcal strains and resistance 
to engulfment has been demonstrated (125, 1^5, 206, 282), 
The use of hyaluronidas© under conditions appropriate for 
its enzymatic action results in a marked increase in 8*8-
ceptibility of treated cells to phagocytosis. Thus, hyals-
Fonic acid appears to be important for establishment of 
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the organisms In the naso-pharynxj, Mhlle M-protein deter­
mines the course of infection. 
Hyaluronic acid of streptococci consists of a copolymer 
of N=ac8tyl=D=glucosaiaine and D-gluouronlc aold (243) with 
a molecular weight of 100,000 to 4,000,000 daltons (282). 
In cultures, especially young ones, hyaluronic acid Is 
found as a capsule probably oomplezed with M-protein (491). 
Hyaluronidase 
Hyaluronldase Is a substance released during the log 
phase of growth by most streptooocei in Group A® Group C 
and Group G (140, 358, 388, 389, 390). It is of particular 
Interest because It has been shown to depolymerlze hyaluronic 
acid by splitting glyoosidlc bonds. This may account at 
least in part for its instability. However, it is difficult 
to demonstrate hyaluronidase in cultures of encapsulated 
strains sTsn after prolonged growth and owmplcte Ivsê 01 
capsules. On the other hand, certain streptococcal strains 
(Type 4 and 22) produce large amounts of hyaluronidase from 
the start of growth and do not form visible capsules in 
vitro (304), Since most patients recovering from strepto-
coccal disease have antibodies to hyaluronidase, it must 
be elaborated Iji vivo (139). 
Hyaluronidase was originally called the spreading 
factor because of its striking lytic effect on the ground 
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substance of connective tissue (8?» 116)» It has long 
been thought to play a role in the characteristic tendency 
of streptococci to spread rapidly through mmmalian tissue 
(166, 208, 239, ^ 88), However, this has not been fully 
investigated. 
Piphosphopyridine nucleotidase 
Most streptocoeeal cultures of Group A and several 
Group C and G, contain a dlphosphopyridin© nucleotidase 
that liberates nicotinamide from dlphosphopyridine nucleotide 
(59» 468, 470), Nephritogenic (Type 12) strains are par­
ticularly prone to produce this enzyme, but there is no 
evidence that it plays a role in the pathogenesis of glo­
merulonephritis (31» 34), Antibodies that inhibit its 
action are frequently found In serum of patients eonvales-
cing from streptococcal disease. The enzyme has also been 
8ho%n to possess leukotozlc and leukooldai properties 
(31, 34). 
Mitogen has been shown to cause transformation of 
lymphocytes to blast celle (60, 84, 46?, 468) and it plays 
a role in the initiation of arthritis in mlee when injected 
concurrently with Streptolysin S (210, 469)» 
Streptolysin S 
The role played by Streptolysin S In vlrulenoe of 
streptococci is not completely understood (175)9 although 
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it has been demonstrated to possess leukooidal and l@uko» 
tozio properties (339)» Streptolysin 8 apparently alters 
permeability of the ©@11 membrane, probably by interacting 
with membrane lipids (15» 122a}« It has been suggested that 
Streptolysin S may suppress the o®llular defense meohanism 
of the host at the site of entry into the body (173, 175)» 
In this way Streptolysin S may ùontrlbate to the enhance­
ment and perslstene® of a ehroni© Inflammatory prooesa in-
dmoed by streptoooeoi and released host cellular enzymes» 
It has also been suggested that Streptolysin 8 may do the 
same to vivo (175) • It also causes degeneration of heart 
muscle and other parenchymatous organs (32, 176, 289, ^^5)® 
Streptolysin 0 
The role of Streptolysin 0 in virulence is unknown 
and bscasse it is 'm of C ««d 
Group G (189, 190)9 which are usually of low virulence for 
man, Streptolysin 0 has been assumed to have littl© impor­
tance as a virulence factor. However, since it possesses 
leukocidal properties similar to Streptolysin 8, it must 
still be considered as a potential virulence factor (33, 
137, 207). 
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Proteinase 
Streptocoooal proteinase is capable of destroying 
another cell factor Involved in virulence, the M-protein 
(123). This enzyme exhibits a relatively broad specificityp 
it may also affect other extracellular proteins such as 
the streptolysins and streptokinase « It is released when 
the pH of the broth medium is between 5»5 and 6,$ 
Under such conditions, large quantities of proteinase are 
released into the medium from which it may be Isolated in 
a crystalline fom» Like many other proteinases it is ac­
tivated by sulfhydryl compounds and causes necrotic myo­
cardial lesions in rabbits when injected intravenously 
(241, 242). The mode of action is not understood, although 
it is believed that these enzymes may either interact with 
components of the cell membrane or other factors that affect 
ceil peraeebility (lyl, lyy, 205)c 
Streptokinase 
In 1933. Tlllett and Garner described a substance In 
culture filtrates of streptococci that promoted lysis of 
human blood clots (476), It was first termed streptococcal 
fibrlnolysins it was later shown to catalyze the conversion 
of plasminogen to plasmln and consequently, it was renamed 
streptokinase (70, 71). Two different molecular species, 
A and B, have been isolated from Group A streptococci 
I&l 
(110). They are Immunogenlo and Induee speelflc antibody 
In the course of most diseases caused by Group A strepto­
cocci (252, 370), Although their action hais been assumed 
to prevent the formation of effective fibrin barriers at 
the periphery of streptococcal lesions» thus permitting 
the organisms to spread %lth unusual rapidity, there Is 
no conclusive evidence to support this hypothesis. In 
fact, development of str©ptoco@cal lesions is apparently 
not influenced by antlstreptoklnase antibody e 
Deosyrlboauolease and Bibenucleage 
Group A streptococci elaborate an enzyme that catalyses 
the cleavage of the 3® phosphate bond of native DM, pro­
ducing 5® terminal fragments of variable lengths, mostly 
larger than dlnucleotldes (I68, 306, 36I). Pour immuno-
loglcally and eleotrophoretloally different types of 
deosyrlbonucleasQ (A, B, C and D) have been found in strep­
tococcal filtrates (^8?)a These enzymes do not penetrate 
the plasma membranes of living mammiallan cells and they 
are not oytotoilc (33® W?), They are capable of depoly» 
merizlng the highly viscous deosyribonuclei® acid which 
accumulates in pus resulting frss disintegration of poly­
morphonuclear leukocytes. Enzyme preparations containing 
both streptokinase and streptococcal deosyribonuelease 
were utilized in such diseases as imeumococcal empyemla 
(477). 
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Deoxyribonuelease production has also been observed 
in Lancefield Groups B, C, D» E» P, G and L, but it is 
produced less frequently and usually in small amounts 
(125). 
Erythrogenlc toxin 
Erythrogenic toxin is the product of streptococcal 
cells that causes the Hell known skin rash seen in scarlet 
fever (108, 109)« Strains of Group A streptococci that 
produce the toxin are lysogenio; however, the amount of 
toxin produced by different lysogenio strains varies 
widely (515). 
There are at least three Immunologically distinct 
forms of erythrogenic toxin (A, B and C) produced by differ­
ent streptococcal strains (515)» They are thought to be 
protein. Certain strains of Group C and Group G hemolytic 
streptococcip as well as staphylococcij produce erythro-
genic toxins closely related to those of Group A strepto­
cocci (302). The toxins are lethal for rabbits (4^0), 
Erythrogenic toxin has beers shorn to suppress reticulo­
endothelial system function (193), antibody formation 
(1#) and phagocytosis (193). These effects could oon-
trlbute directly to virulence, 
Cell-sensltlglnm factor of streptococcal origin 
The cell-sensitizing factor has been shown to sensi­
tize a variety of cells to lysis by antiserum and complement 
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(112, 196, 328» and to Indu©® arthritis in animals 
(172). E^ldeno® that the factor plays a significant role 
in tissu© injury was reviewed recently (173), 
C-polysaccharlde 
The "C substance is not considered to play any role 
in the virulence of streptococci (173)® Purified "C® 
substance, injected intravenously into rats, rabbits and 
guinea pigs, was eliminated by the kidneys within 30 min­
utes without any evidence of pathological change (396). 
Mucopeptide 
Mucopeptlde, injected intradermally into rabbits or 
guinea pigs, caused acute necrotic lesions with massive 
infiltration of polymorphonuclear leukocytes* It has also 
been shorn to inhibit phagocytosis ^  vitro (230), to 
cause necrosis of skin (2), to be pyrogenic (385) and to 
enhance the resistance of animals to subsequent challenge 
with streptococci (386). 
Mucopeptide and carbohydrate complexes 
Complexes of these substances have been shown to be 
involved in tissue injury (17^)« However, the specific 
nature of the action has not been determined. 
Streptococcal antigens cross reactive with tissue 
There is a large body of evidence for the existence 
of antigens common to streptooocci and mammalian tissues 
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(483)« Cross reactions have been demonstrated between 
components of streptococcal cell %all (234) or protoplast 
membrane (158, 516), with cardiac and skeletal musole 
(262), smooth muscle of bleed vessels (174), basement 
membrane of the kidney (280, 290, Z9ip 292), monopoly-
saccharlde of heart valves (235)® connective tissue (179) 
and certain transplantation antigens (67, 367, 369), The 
role of these antigens in tissue damage has been reviewed 
recently (174), The antigens apparently do not have a 
specific role as virulence factors, although, they appear 
to be Involved in initiation of certain autoimmune diseases 
and sequelae such as rheumatic fever and glomerulonephritis 
(174). 
Miscellaneous aspects of streptococcal virulence 
Breese et (1970) reported that the number of beta 
hemolytic streptococci fowiiu Guitar G s has grsst clinieal 
and epidemiological significance. They felt that in the 
individual patient, clinical disease was usually associated 
with a large number of streptococci; however, in cervical 
adenitis, unruptured otis media, acute glomerulonephritis 
and rheumatic fever they suggested that a few streptococci 
were significant (46), 
Cayeuz et al» (62, 63, 64) have presented evidence 
that there are essentially two genetically different types 
of bacteria In certain strains of Group A streptococci. 
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One type, "vm", causes lesions but they are not necessar­
ily fatal. The other type Is called virulent or "BM" 
because they cause a rapid death by septicemia In mice. 
Virulence Is linked to a genetle character that Is not 
carried by all organisms In a given culture but only by 
a certain proportion of them (3%6)« However, this concept 
has not been substantiated. 
An adhesivee eell-assoclated polysaccharide is one of 
the more important determinants of virulence of carlogenie 
streptocoooi (170). This polysaccharide is composed of a 
mixture of dextrans with an alpha 1-6 linkage between the 
glucose units with alpha 1-3 and 1-% branches (466), 
Reduction in the formation of the adhesive deztran results 
in a decrease of the cariogenic potential of these strep­
tococci. 
Of 50 strains of streptococci cultured from blood of 
patients with baoterial endocarditis, 17 belonged to Group 
H (125)® The virulence of this group was related to the 
®stickiness® of the bacteria associated with deztran pro-
ducticHi The destran f®eilit-at®4 haoterial adhesion to 
the heart valve. 
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Serological Response to Streptococci 
Streptococcal antibodies have been detected with 
complement-fixation (4), 50?)» active and passive nouse 
protection (44, 143, 277), bactericidal (269, 297, 460, 
461, 479), bentonite flocculation (284), indirect hemagglu­
tination (105, 146, 364, 399; 518)0 fluorescent antibody 
(321), latex fixation (I36), quantitative precipitation 
(18, 19, 397), long chaining ( 120, 121, 187, 459) and 
Immunodiffusion (I9I) procedures. A variety of antigens, 
some crude and others highly purified, have been used. 
The majority of work has been related to Group A strains, 
although, a little work has also been done with some of 
the other groups (47), 
During the early period of investigation of strepto­
coccal immunity, procedures were developed for evaluation 
of bactericidal and/or bacteriostatic antibodies, Rothbard 
developed the indirect bactericidal test to evaluate the 
serological response (383)» It was clearly demonstrated 
that acquired resistance to Group A steptococci was depen­
dent upon the presence of circulating antibodies to the 
specific M-antigen« 
Antibodies to M-antigen developed during streptococcal 
infection in most persons (363, 383, 398), The anti-M-
antibodies are type-specific and immunity depends upon 
k7 
them, Antlblotlo treatment substantially decreases their 
production (93). It has been shomi that a significant 
rise in specific antibody follows streptococcâl infections 
in 92 per cent of Individuals not treated with penicillin 
(106)0 In contrast to antibodies against extracellular 
streptococcal products, M-protein antibodies develop 
rather slowly. Differences in the time of appearance of 
antibodies to the individual types can be shown to depend 
on antigenicity of the M-protein of specific types» Mtl-
H-antibody generally reaches the highest titer two months 
after the beginning of an infection (^33)» Lancefield in 
1959 desionstrated that anti-M=antibodies were present 10 
to 32 years after streptococcal disease in about half of 
the subjects studied (271)® 
The lower incidence of streptococcal disease in younger 
ohiidren and a different clinical course of illness suggests 
a relation between the type of disease and previous e&po-
surso ThwSj development of Immunity and hypersensitivity 
may play an important role in streptococcal infections* 
Passive Immunity In Group A 
Immunotherapy to various streptococcal infections 
initially Involved the use of antiserums « Marmorek reported 
that he had obtained an antistreptococeal serum by the 
Injection of horses with whole cells derived from several 
species of streptococci (293)* With this antiserum, he 
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successfully treated cases of erysipelas, puerpural fever, 
phlegmon, streptococcal sore throat and mixed infections. 
He noted particularly good results in eases of scarlet 
fever. Others have reported suoessful use of strepto­
coccal antiserums for treatment of streptococcal diseases 
(37, 113, 164, 409, W6). 
Several Russian publications concerning induction of 
immunity to scarlet fever appeared in 1906 and 190?o One 
series of papers demonstrated that scarlet fever strepto­
cocci produced a filtrable tozin that stimulated develop­
ment of an antitoxin (394), In another series, it was 
demonstrated that a vaccine made from formalized gtole 
cell cultures and broth filtrate protected children from 
scarlet fever (I63, I65)» 
In the human, antibody to streptococci can be passed 
from mother to the fetus via the placenta. Qmirm arid 
Lowry (362) demonstrated that type-speoific M-prot©in anti° 
bodies in oord blood of 7 of 9 infants sere the saae type 
and in similar titers to those In the mother's serum. 
These antibodies disappeared from the serum of the neonates 
by the fifth post-natal month. 
Passive hemagglutination, performed on 107 paired 
huiaan maternal and cord speoimeas, demonstrated placental 
transfer of type-speelflo streptocoooal antibody In ?8 per 
cent of these cases. The oord serum also demonstrated 
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bactericidal activity equal to that of the mother and this 
correlated with the passive hemagglutination titer. The 
IgM level ms significmitly higher in the cord ser# from 
these infants than control cord IgM levels (51?), 
Active Immunity 
A number of attempts have been made to induce active 
Immunity in humans against Group A streptococci. In most 
early attempts, the role of type-speclfic antigen in pro­
tection was not recognized, therefore whole cell vaccines 
were used. Often these vaccines caused such violent local 
and systemic reactions In the recipients (366) that the 
projects were terminated in spite of the fact that typ#= 
specific antibody, as detected by bactericidal and passive 
mouse protection tests, was induced in some individuals 
(458, 514). 
Onoe M»proteln had been accepted as being the most 
important antigen In relation to virulence and Immunity, 
investigators evaluated procedures for obtaining and 
characterizing this antigen. Many articles have been 
published on the antibody response of rabbits to M-proteln 
(148, 197, 233, 247), 
In an early attempt to produce a purified M-proteln 
vaccine for human use, Schmidt used s hot acid eitraot 
that had been partially purified by acid precipitation, 
ribonuolease digestion and ammonium sulfate precipitation 
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(398), This material was used to vacelnate adults and 
children® The vaccine did not cause any untoward reactions 
in the recipients. Precipitating said bactericidal anti­
bodies were detected in only 5 of 29 individuals who 
received the vaccine, 
Massell et al, (29%, 295) prepared a partially purified, 
M-prot@ln antigen from a hot acid extract of a type 3 Group 
A streptococcus. Bactericidal antibody developed in 13 
of 14 individuals vaccinated Intradermally with the extract, 
Anamnestic responses were detected in ? individuals with 
pre-existing bactericidal antibody. Subsequent to vacci­
nation e 3 instances of rheumatic fever #ere observed in 
the vaccinates. 
The recall of type-specific antibodies in man by 
administration of streptococcal cell walls containing 
M-proteln has been demonstrated by bactericidal and long 
chaining tests (360), 
Pes and his assoGlates have obtained promising results 
using highly purified M-protein from specific types of 
streptococci. These purified M-prot@ins were antigenic* 
protective and non-tosie in individuals who were not pre­
viously sensitized. Purified M-proteln from as many as 
^ different types of Group A streptococci were used in 
combination as a polyvalent vaccine (148, 344), 
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Itolng the last 10 years, over 150 adults and 90 
children have been vaeclmted with vaceinee prepared with 
purified M»protein from several of the more oesmon s@ro» 
types (1, 3, 4, 6 and 12) (153, 15%, 155, 344). The 
immunization scheme has eonsisted of three doses of 50 
ug per injection of M-protein precipitated mith alum» 
With this type of vaccine, it nas possible to induce a 
streptococcal antibody response in about 75 per cent of 
the young children as determined by the indirect bacteri­
cidal test mid the micro complement-flzation test (154)» 
By selectively screening prospective vaccinees, it was 
possible to avoid local and systemic reactions to the 
vaccine, The micro complement=f i%ation procedure, using 
highly purified M-antigen, has been suggested as an index 
of protective antibody in Group A immmity (507)« 
X'ri â prooeutlv"® âtuû^  uslug uuSâîi "vûluixtôcî?» 9 Poï 
et ale (15-4) demonstrated that an alumcprecipitated, 
antigen vaccine afforded protection against an upper 
respiratory type 1 streptococcal infection. Only 1 of 19 
vaccinates demonstrated signs of clinical illness@ whereas 
9 of 19 placebo vaccinates were ill following infective 
challenge, No correlation was observed between challenge 
results and serological titers. 
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Group B 
Unlike Group A streptoooeol, mastitis streptooooci 
do not have a potent array of immunogenic virulence factors 
(395). The various antigens used in serological typing 
of Group B streptocooci do net play any significant role 
in virulence, A cell associated component, *8 polysac­
charide* e that plays an important role in virulence has 
been described, however, protective antibodies apparently 
are not formed against it (96, 286, 395)» 
Although S8 aaalaotiae has relatively low virulence 
for laboratory animals, Norcross et al« (336) developed 
a mouse protection test for use in assaying streptococcal 
antibodies in bovine serum and milk. The test was reported 
to directly measure immunity provided low levels of 
streptococci were used to challenge the animals, Antl-
bodies against cellular antigens in goat and bovine serum 
oan also be tested by mouse protection (334, 336, 3^7)s 
precipitation and eoaplemerit-fization (55, 333). Unfcrtu= 
nately, none of these procedures have been shown to measure 
antibody that is related to protective immunity & 
Experimental 8, egalactiae vaoolnes have been produced 
for over two decades and they have produced variable results 
when used as cures or prophylactics in bovine mastitis 
(450). Carpenter (61) found that those cows which received 
several subcutaneous inoculations of 8, aRalaotlae 
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experienced a shorter period of clinical disease and a 
less severe inflammatory reaction than unvaccinated cows. 
In another study (^5), vaccinated cows became free of 
infection and had lower neutrophil counts than controls 
following challenge with the organism. In a test under 
field conditions, there was a minimum level of statistical 
significance in favor of vaccinated ©owso 
Norcross et al. (336) have presented information on 
use of an autogenous bacterln in cattle. This vaccine 
consisted of formalin inactivated whole cells. Five 1 ml 
doses were inoculated in the area of the right supramammary 
lymph node at weekly intervals. Vaccinated cattle resisted 
challenge with the homologous strain. Results obtained in a 
passive mouse protection test with antiserum from a cow 
immunized with a whole cell bacterln containing S. agalao-
type-specific (335)» 
Johnson and Noroross (224) obtained encouraging results 
in a dairy herd id.th S, agalactlae mastitis using a forma­
lized whole-cell vaccine combined with antibiotic therapy 
of infected quarters® 
Kozlowskl (250) reported some success using an autogen­
ous, formalin-killed9 whole cell vaccine. The vaccine was 
injected under the skin of the udder of 10 cows with 
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mastitis. Five of the animals responded with an increase 
in whey agglutinins. Two animals developed purulent mastitis 
but recovered. 
Group C 
The serological and protective immune response to 
Lancefleld Group C can be divided into three sections; 
equine» bovine and swine. The Immune response has been 
evaluated more extensively in the horse and bovine than 
In the pige 
Group C streptococci are the most frequent primary 
or secondary causes of pyogenic Infections of the horse 
(24, 25» 51» 111, 118), Bazeley and Battle, working In 
Australia, made probably the most significant single con­
tribution to understanding of strangles when they identified 
8. equl as the causative agent (25). Through cross Immunity 
studies in mice âfld Clinical evidence from the field, 
Baseley demonstrated that only one protective antigen was 
associated with the capsule of equi (23), He also demon= 
strated that circulating antibody played a role in the 
defense mechanism against equine strangles. Immunity to 
strangles depends on the animal's coming in contact with 
living or dead capsule material (22), Protection has been 
attributed to an antibody that alters the capsule. 
In recent work, Woolcock (512), demonstrated an M°like 
material that is associated with the capsule of S, equi. 
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Purified preparations of the material elicited protective 
antibody in vaccinated animals as evaluated "by live 
challenge. Protection was directly related to the presence 
of anti-M-like antibodies. 
S. dysgalactlae is responsible for 8 to 26 per cent 
of the clinical cases of bacterial mastitis in the bovine 
(119), Stark and Norcross developed a passive hemagglu­
tination technique for detection of S, dysgalactiae anti­
body in serum of rabbits and cattle (^53» ^5^)« It was 
demonstrated that most adult cattle had S. dysgalactiae 
hemagglutination titers of 1*80 or more, presumably acquired 
from inapparent infections. Formalin-killed, whole cell 
bacterlns induced Increased antibody levels in cattle #lth 
pre-existing antibodies (511), Results obtained by use of 
a passive mouse protection test indicated that serum from 
the vaccinated cows contained protective antibodies. Evi­
dence has been obtained that clinical signs and actual 
infections have been reduced by use of the 8« dysgalaetlae 
vaccine (455) <> 
Immunization procedures* based on use of autogenous 
bacterlns, for the control of Group C infections in swine 
have been reported (195» 200), Hare et (195) prepared 
an autogenous, formai!zed-whole cell culture vaccine to 
control beta hemolytic streptococcal infection In swine. 
The vaccine was administered as a curative at ((-S hour 
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intervals in sis doses aach of 2 ml for suokling pigs 
and 81% doses each of 5 ml for sows. As a preventive, 
the vaccine was given at intervals of seven days in three 
doses of le 2 and 3 ml to suckling pigs and 5» 10 and 15 
ml to adult swine. According to the authors, this vaocin® 
significantly reduced the incidence of disease attributed 
to beta hemolytic streptccocci. 
Helms (200) reported a reduction in the incidence 
of navel Infection when sows were vaccinated before 
farrowing with either an autogenous bacterin or a commer­
cially available mised bacterin. 
The species of beta hemolytic streptococci used by 
Hare al, and Helms were not reported; however, because 
it is ubiquitous in swine, it ie likely that they were 
working with 8. equisimills. 
Group D 
Vaccination and challessge studies utilizing Group D 
streptococci in swine were not found in the literature, 
Elliot et al. and Agarwal et ale successfully protected 
pigs against Group D by administration of iEsmune serum 
from sows or other previously exposed pigs (4^, 5, 6, 129, 
130). 
Some vaccination and challenge studies have been 
conducted in rats and hamsters with dental caries induced 
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with S, mutans» a Group D species. Variable protection 
occurred following virulent challenge (466), 
Agarwal et (4, 5, 6) reported that swine over 8 
weeks of age generally had protective levels of antibody 
directed specifically against the capsular polysaccharide 
of Group D streptococci. Results obtained ^  vivo suggested 
that swine under 4 weeks of age were very susceptible to 
broth cultures sprayed into the naso-pharynx. With in­
creasing age the blood of swine became Inhibitory to the 
growth of Group D streptococci. This effect was correlated 
with a decrease in susceptibility to infection. Swine of 
any age reared in a pathogen free environment did not 
develop resistance. Thus, immunity against Group D strep­
tococci in older conventional animals apparently arises 
from inapparent infections. 
Group E 
Swine exposed naturally or experimentally to Group 2 
streptococci (the cause of streptococcal lymphadenitis in 
swine) have been reported to develop humoral and cellular 
immunity directed against the organism. Circulating anti­
bodies against Group E streptococci in swine serum have 
been evaluated by agglutination (132, 429, 438), precipi­
tation (427, 494), hemagglutination (493), immunodiffusion 
(430, 431, 432) and bactericidal (56, 57, 58, 94) teats. 
The leukocyte migration inhibition test (58) and cutaneous 
i 
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reactions to exoantigens have been used to evaluate 
hypersensitivity (4^7, 428), The antigen responsible for 
induction of protective iiaamnity in swine against strepto­
coccal lymphadenitis has not been defined. The reported 
success of an orally administered» live-attenuated Group E 
vaccine suggests that protective immunity to streptococcal 
lymphadenitis may be cell-mediated or secretory in nature. 
However, proof of this point has not been presented. 
Serotype IV has been the most frequently reported 
Group E type isolated from field cases of streptococcal 
lymphadenitis (381, 513)» although Sypes II, V and several 
untypable strains have also been isolated. Because of 
the relatively high Incidence of serotype IV® attempts were 
initiated to develop a bacterin to control the disease. 
However, autogenous and/or serotype IV bacterins have proven 
imBiîcoesgf-ul (182; 438), Collier ©riglrjally evaluated s 
formalin-killed whole-cell bacterin and reported that his 
results were inconclusive (76), Conner et (83) evalu­
ated an autogenous bacterin prepared from hemolytic strep­
tococci and staphylococci and a commercial bacterin con­
taining organisms isolated from cattle in bred sows and 
gilts. It was suggested that use of the bacterin reduced 
the number of pigs that died before weaning and the occur­
rence of abscesses in pigs, 8human and Wood (429) also 
evaluated formalin killed bacterins for prevention of 
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abscesses» Utilizing either whole cells and adjuvant or 
cells resuspended in a concentrated culture filtrate (428) 
combined with adjuvant» they failed to demonstrate protec­
tion In 38 of 41 vaccinated animals, although a rise in 
agglutinating antibodies was demonstrated in the vaccinates. 
Collier (79) reported that swine actively Infected isith 
Group E streptococci were Immune to subsequent challenge# 
In a study by Engelbrecht and Dolan (135)» swine experimen­
tally infected with Group E streptococci resisted subsequent 
challenge with the same organism. They also reported devel­
opment and efficacy testing of a modified, live culture, 
Group E vaccine. When administered orally, the vaccine 
produced no evidence of increased virulence and protected 
88 per cent of swine vaccinated at 10 to 15 weeks of age 
(134)* In field trials, vaccinates and controls remained 
together at all times and the controls remained susceptible 
to challenge indicating that the avlrulent strain was not 
transmitted from vaccinates to controls. The strain did 
not revert to virulence in 5 serial passages In swine. 
Efficacy of this vaccine has been reported by other 
investigators (75, 217). 
Thus streptococcal Ijrmphadenitis caused by Group E 
streptococci of serotype IV may be controlled by oral 
administration of an avlrulent live culture (75, 133, 134, 
217). 
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Cllnlcopathologlcal Entities 
The genus Streptococcus contains organisms that are 
among the most important bacterial pathogens of man and 
animals. They have the capacity to invade any tissue or 
organ and the range of resulting clinical syndromes is a 
reflection of the different sites of invasion and conse­
quent host-parasite relationshipso Representative strains 
from every known or proposed Lancefleld serological group 
and many not yet grouped have been isolated from swine 
(^26), Some of these organisms have been associated with 
diseased tissue while others are from apparently normal 
individuals» 
Streptococci have been isolated from a wide variety 
of tissues in swine and from swine of all ages. The most 
frequent manifestations of streptococcal infection are 
arthritis (78, 142, 184, 316, 330, 415, 464, 478), endo-
carditis (21, 95, I67, 212, 215, 228, 240, 244, 481), 
meningoencephalitis (86, 219, 314, 315, 327, 371, 408) 
and cervical abscesses (9, 10, 73, 74, 77, 97, 98, 99, 
226, 329,444,452, 513), Miscellaneous diseases that have 
also been occasionally associated with streptoeoceal in= 
fectlon includes abortion (84, 85, 188, 25I, 393), infer­
tility (114, 200), acute death (7» 52, 195» 484), enteritis 
(100, 251, 371), metritis (228, 475), mastitis (12, 65, 68, 
5Ï 
4^6, ^ 7%) and dermatitis (78, 195)• 
Arthritis 
The most frequent causes of suppurative arthritis in 
swine from birth to 6 weeks of age are members of the genus 
Streptococcus, principally S. equisimilis (381). The 
literature on streptococcal arthritis in swine consists 
primarily of case reports and surveys. In an early report. 
Field et al, {1^2) indicated that streptococcal arthritis 
was common in young swine and that infection might be con­
fined to a single litter or in successive litters over a 
period of many months® The role of the enviromental sources 
and other non-swine sources in the spread of the infection 
is not understood, although the age of the pigs involved 
strongly suggests that the so* is the most probable source 
of infection (lt2, 195, 200), 
Collier (78) studied 13 isolates of beta hemolytic 
streptococci isolated from arthritic lesions of sHlne 
and found 10 of them to be S. equisimilis. Switzer ^  al. 
in unpublished work cited by Switzer in 196^ (46^), 
isolated beta hemolytic streptococci from l6 of 107 ar­
thritic joints of pigs of market weight and from 9 of 
'4-8 arthritic joints of pigs market weight and over@ 
Twenty of the twenty-five beta hemolytic streptococci were 
later reported to be 8. equisimilis (374), Tittiger and 
Alexander (%78) isolated 50 beta hemolytic streptococci 
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from 4-78 joints of arthritic swine cultured at slaughter? 
28 of the Isolates were Group C» 21 Group L and 1 Group 
E. Nielsen et al. (330) In Denmark studied polyarthritis 
in 126 litters and found 11? of 722 nooropsied swine had 
lesions of arthritis. Hemolytic streptococci accounted for 
67 per cent of the bacteria isolated. The majority of the 
Isolates belonged to Lanoefield groups C asid L. Roberts et 
al» (37^ 1 isolated S. equisimilis from swine with naturally 
occurring arthritis and reproduced the disease in young pigs 
by intravenous inoculations of fresh broth cultures of the 
isolate. They were unable to produce the condition by any 
other route of inoculation (375» 376)* Khan (2^5) also re­
produced the condition by intravenous inoculation. Shuman 
! 
and Wood (430) produced chronic suppurative arthritis in 5 
of 6 hysterectomy-derived pigs by subcutaneous and intra-
Tsnous Injscticn of S. zccspldssisus. In this 22=2 study, 2 
strain of S. equlslaillg of equine origin failed to produce 
arthritis in 6 pigs following intravenous injection. How­
ever „ S, equisiiailis Eras isolated from tonsils of over 50 
per cent of the swine= Shuman and Wood speculated that the 
inoculated pigs may have been exposed previously and thus, 
they could have developed protective immunity. 
Arthritis has also been experimentally produced in 
swine vlth strains from groups A (432, 509)» D (129, 130)» 
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E (4o6, ko?), L (22?) as well as several non-grouped 
strains (^25). 
Endocarditis 
A wide variety of streptococcal species have been 
associated with endocarditis in sMine; however, E, rhasio-
pathiae (2^0) is the principal cause of valvular lesions 
in swine® Kernkemp (244) reported that in 8 cases of 
streptococcal endocarditis 5 of the organisms isolated were 
beta hemolotic streptocoeei, One of the organisas was 
closely related to 8, fecalis and the other was related 
to the enterococci» Hofferber (212) reported that 5 baby 
pigs in one litter died 8 days to 3 ^ eeks after birth 
with streptococcal endocarditis. He concluded that an 
intrauterine infection had occurred. 
In 19669 Bstis et (21) examined 72 streptococcal 
strâluS firûm SWlïlB ëMuCiûêif ul til a âuu Iwcwvlf lôu 17 
zooepldemlGus, 18 Group D, 5 8= uteris: they were «nabi© 
to classify 32 others, Tomita et al» (481), in Japan* 
found endocarditis in 212 of 97,952 pigs inspected at 
slaughters Streptococci were isolated from 23 of the 
212 cases. 
Death of 8 sows in a commercial herd was attributed 
to streptococcal endocarditis by Jones (227, 228, 229), 
Seven strains of streptoeoeoip 4 Group L, 2 Group C and 1 
unidentified, were isolated. 
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Kast (240) reported an evaluation of 252 cases of 
"bacterial endocarditis In swine at slaughter. He found 
that about 4/5 of the causative organisms were E, rhuslo-
pathiae » %hlle streptococci and gtaphylococGi accounted 
for approximately 10 per cent and all other bacteria only 
1 per cent. He isolated strains of streptococci from 
serological groups A, B, C, D, E, L and N, 
Endocarditis has been reproduced In young pigs by 
intravenous injection of streptococci from Group D (129, 
130) and Group L (22?, 228, 229), Hont and Banks (215) 
used increasing doses of beta hemolytlo streptococci from 
Group D to produce endocarditis9 Cotchin and Ha^ward (86) 
injected two pigs intravenously with a single dose of an 
alpha-hemolytlc streptococcus isolated from a natural case 
of porcine endocarditis, T^o other pigs were given repeated 
intravenous injections with the same straino îmorôsôôpiô 
lesions of endocarditis were found in one animal and histo» 
logical lesions in the ether animal of the pair receiving 
the single dose. Jones (228) reproduced endocarditis in 
6 of 10 swine inoculated with a single Intravenous injection 
of a Group L strain originally isolated from a natural case. 
The majority of inoculated swine also developed arthritis, 
Menlngoenoe phalitie 
Various species of streptococci have been Isolated from 
meningoencephalitis of swine, McNutt and Packer (315) 
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reported several outbreaks of meningitis In baby pigs 
from which gamma and beta hemolytic streptococci were 
isolated® The isolates were very heterogeneous biochemi­
cally and no single species appeared to be involved in the 
disease condition. The authors suggested that the disease 
developed in pigs with lowered resistance because none of 
the strains were recognized at that time as being patho= 
genie streptococci. Field et al. (142) isolated a beta 
hemolytic streptococcus from a similar condition that later 
was reported by de Moor (101, 102, 103) to cross react 
with antiserum prepared with streptococci of his proposed 
Group So McErlean (31%) reported an outbreak of meningo­
encephalitis in a litter of pigs 4 weeks old. He isolated 
a motile, pleomorphic non-hemolytic streptococcus from 
the brain. The strain did not correspond to any of 
Lancefield groups A through G, The condition was reproduced 
in young pigs following injection of culture of the organ­
ism, Schulte (408) described an outbreak of diplococcal 
encephalitis in 15 pigs 3 to ^ weeks of age, Alpha-hemolytic 
streptococci have also been isolated from baby pigs with 
the disease {327)» This condition is still reported to 
occur in European swine (5%, 330» 359, ^35» 465) but no 
reports of the condition in American swine have been reported 
since that of Ray in 19^5 (371), 
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Abscesses 
Abscesses of the head and neck of market pl,rs are 
caused primarily by Group E streptococci (9, 77, 99» 226, 
513) » although several other organisms have also been 
associated with the condition (426)» 
Newson (329) described cervical abscesses in swine 
and stated that a beta hemolytic streptococcus could be 
isolated from the exudate. Stafseth and Clinton (452) 
reported Lancefleld typing of the streptococci isolated 
from swine abscesses. These reports demonstrated that 
the original suggestion of Lancefleld that Group E organ­
isms were associated with dairy products needed to be 
modified. It was suggested that cervical abscesses were 
spread by means of mechanical transmission. However » 
Snoeyenbos et (444) were unable to transmit the organ» 
ism by vaccination and they suggested that mechanical 
transmission was not a major factor in the disease. 
Collier found the disease to be enzootic on some farms 
where it affected pigs of all ages. However, the abscesses 
were not usually detected until the swine were slaughtered 
(77). 
Delbil et (97, 98, 99) evaluated 37 Isolates of 
Group E streptococci and found them to be physiologically 
homogenous. They found these isolates to be non-pathogenic 
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for comaon laboratory animals, However, in subsequent 
work, Cutllp and Shumaa (92) have shown the rabbit to be 
susceptible to a group E Type IV strain. 
Cervical abscesses can be regularly produced in 9 to 
Ik week old pigs by giving Group E organisas In the feed 
(77» kOOf 401). Intranasal and Intrapharyngeal inocula­
tion of the above organisa produced similar lesions but 
inoculation by various other routes failed to Induce abscess 
formation (288). 
Reports by various investigators (11, 288, 402) have 
indicated that 9 to week old swine are more susceptible 
to Group E streptococci than younger or older swine. 
Collier (76) suggested that the sow was the source of 
Group E streptococcus infection for young pigs. la sub­
sequent work, Collier and Noel (81) and Schmitz and Olson 
yo4) demonstrated transmission of Group S streptoeoeci 
from carrier swine to susceptible swine. Collier and Noel 
(80) were able to isolate the organism from tonsil swabs of 
the carriers, although Schmitz and Olson were unable to lso<= 
late the organism from tonsil swabs of known carriers. 
Schmitz and Olson (400) demonstrated that Group E streptococci 
could survive in soil for up to 31 days at 37 C, 
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MATERIALS AND METHODS 
StreptococMÎTCxrrbures 
Source of strains 
Five strains of S, equlsimllis of swine origin were 
used. Four of the strains, 78-A, R-8, 78-B and F=49 were 
originally isolated from arthritic joints of pigs or repro­
ductive tracts of sows (24$)« The fifth strain was obtained 
by passing strain 78-A through Caesarean-derlved colostrum-
deprived (CDCD) 6 week old swine 3 times. Two animals were 
inoculated intravenously with 1 ml of a 6 hour Todd-Hewith 
broth^ (THB) culture and observed for symptoms of arthritis. 
When lameness and joint swelling were observed, the animals 
were necropsled, fluid from arthritic joints was collected, 
streaked on blood agar and incubated for 18 hours at 37 C. 
Typical S. eQt>xsimilis colonies were picked to THB; inc.v.bated 
for 6 hours at 37 C and reinoculated into swine. This pro­
cedure was repeated 3 times and the isolate from the third 
pig passage was designated 78-A3X, The identity of each 
inoculated strain was determined by biochemical and sero­
logical comparisons with the parent strain. 
^Dlfco Laboratories, Detroit, Michigan» 
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A S. zooepidemlcus strain of unknown host origin was 
obtained from R, A, Packer,^ S, equi 658O and Group L 9932 
strains were obtained from the American Type Culture 
Collection.2 
Comparisons of biochemical activity of strains of 
S. equisimilis were done in phenol red broth base^ plus 
ieO per cent of the appropriate sugar. Media were inocu­
lated with one drop per tube of 24 hour TH3 culture, incu­
bated aerobically at 37 C and observed for acid production 
at 24 and 48 hours. 
Hemolysis was determined at 24 and 48 hours incubation 
at 37 C on 5 per cent horse blood agar, Lancefield grouping 
serums, obtained from commercial supply houses,3* ^  were 
used with capillary pipettes^ (0,7 to 1,0 mm) to identify 
group antigen. Serotype specificity was determined by 
using hyperimmune rabbit antiserum against four known 
swine 8, equisimilis serotypes (246), 
^R, A, Packer, Iowa State University, Ames, Iowa, 
^American Type Culture Collection. Rockville. Maryland. 
3Difeo Laboratories, Detroit, Michigan, 
^Burrough Wellcome Co., Tuckahoe, New York. 
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Stock cultures 
Stock cultures of all streptococcal strains were 
prepared as soon as the strains were received or isolated» 
Low passage cultures were inoculated into THE using approx­
imately 1 per cent inoculum, the cultures were incubated 
16 to 18 hours at 37 C and examined microscopically for 
purity» Cultures were oosbined with equal volumes of 1 
per cent skim milk, dispensed in 1 ml ampoules and lyophi» 
lized.l The stock cultures were appropriately labeled, 
examined for purity and stored at 4 C, 
Working cultures 
Working cultures were produced by inoculating 1 vial 
of stock culture into 25 ml of THB which was then incubated 
for 18 hours at 37 C. Following microscopic examination 
for purity, the cultures were lyophilized according to the 
above procedure, labeiea, again esaisined for purity and 
stored at ^ C. The bioohesical and serological identity 
of the working cultures were determined ss described pre-
viously. Working cultures were used for production of 
streptococcal vaccines, sonic-derived antigens and acid or 
alkaline extracts. All cultures used were no more than 5 
passages from the original source. 
iThe Tlrlis Cor,, Gardiner, New York. 
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Virulence 
Virulence of stock and working cultures was compared 
by determination of the LD50 of each culture for mice. 
Cultures were grown 6 hours in THB and 10 fold dilutions 
were prepared in 1 per cent neopeptone. 0,25 ml amounts 
of each dilution were given intraperitoneally to each of 
10 mice. Virulence of the organism was enhanced "by simul-
tsaieous Intraperitoneal inoculation of 0«15 ml of 5 per cent 
gastric mucin type The death pattern was monitored for 
1 week. 
Virulence of S, equlsimilis for swine was determined 
by intravenous inoculation of 3 to 6 week old CDCD pigs 
with a 6 hour broth culture. In these experiments at least 
2 animals were inoculated for each 10 fold dilution and 
clinical signs were observed for 5 days. Animals were 
necropsled after 5 days for evaluation of gross lesions 
and collection of smnples for bacteriological examination. 
Antigen Preparations 
Hot acid extraction 
Hot acid extracts were prepared according to a procedure 
originally developed by Lancefield (265) and modified by 
Lancefleld and Perlmann (278), Streptococcal cells grown 
^Wilson and Co., Chicago, Illinois, 
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for 16 to 18 hours at 37 C In THB were harvested by oentrif-
ugatlon, at 2,GOO g for 30 minutes at 4 C and washed once with 
0,1 M potassium phosphate buffered saline,pH 7*0, The sedi-
mented cells were mixed with an equal volume of N/5 HCl, 
heated in a boiling water bath with occasional shaking for 
10 minutesf cooled and recentrifuged. The supernatant was 
decanted Into a screw capped vial and a small drop of 0,01 
per cent phenol red was added to give the solution a yellow 
cast. The fluid was neutralized by adding N/5 NaOH in M/15 
phosphate buffer until it became pink. The pH ^ as estimated 
with hydrion papers^ and appropriate acid or base added 
until the solution was in the pH range of 7«0 to 7,8, This 
solution was centrifuged at 5,000 g for 30 minutes at 4 C 
to remove any insoluble material and stored at «20 C until 
used. 
Alkaline extraction 
The alkaline extraction procedure originally developed 
by Pox and Wittner was used with modifications (152), 
Streptococcal cells grown for 16 to 18 hours in THB were 
harvested by centrifugation and washed in 0,1 M phosphate 
buffered salins, pH 7.0 (PBS»?), A 25 per cent v/v suspen­
sion of cells in PBS-7 was adjusted to pH 10 ^ ith 1,0 M 
NaOH; heated in a boiling water bath with occasional shaking 
1 
Micro Essential Laboratory, Brooklyn, New York, 
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for 10 minutes, cooled and recentrifuged. The supernatant 
fluid wap removed and the cells were extracted a second 
time according to the procedure described previously. The 
supernatant fluids from both extractions were pooled, neu­
tralized with 0.1 M HCl and recentrifuged at 10,000 g for 
30 minutes at 4 C to remove insoluble material. This 
material was stored at -20 C until used. 
Pressure disruption 
THB was seeded with 1 per cent inoculum of a î6 to 18 
hour streptococcal culture, incubated at 37 C for 18 hours 
and the cells Mere harvested by centrlfugation at 27,000 g 
with a refrigerated continuous flow centrifuge,^ Sedimented 
cells were resuspended, rinsed once with PBS-7 and resuspended 
in the same buffer at a concentration of 10^^ CPU/ml, The 
cells were held at 4 C until used. 
Cells were disrupted with a French pressure cell in a 
power laboratory pressThe cell suspension was passed 
through the pressure cell 3 times at a minimum of 18,000 
pounds per square inch. The disrupted cell walls were 
sedimented by centrifugat-ion as described previously and 
stored frozen at -20 C, 
^Model RC2-B. Ivan Sorval, Inc., Norwalk, Connecticut. 
^American Instrument Co., Silver Spring, Maryland. 
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SonicatIon 
Streptococcal cells from a 16 to 18 hour THB culture 
were washed In 0.1 M potassium phosphate buffered saline» 
PH 7.55» and resuspended In the same buffer so that 1 ml 
contained approximately 10^0 CPU. The number was determined 
by actual plate count. 
The suspended organisms were placed in a glass beaker 
and the beaker was placed in a crushed ice-salt bath main­
tained at a temperature of 0 to 4 C. Sonicatlon was per­
formed with a 12 mm ultrasonic probe^ inserted approximately 
3 to 5 mm into the suspension, Sonicatlon was usually done 
at 90 to 95 per cent full power for 20 minutes» although 
other intervals and exposure times were utilized. After 
sonicatlon, the suspension was centrifuged at 500 g to remove 
whole cells and then frozen for vaccine use or processed 
further for other antigen preparations. 
Partially purified antigen 
Partially purified, type-specific antigen was prepared 
according to the procedure used by Foz and Wittner (150). 
Cell walls were obtained by passing a slurry of cells in 
PBS-7 through a French pressure cell at 18,000 lbs/in. or 
from sonlcally disrupted cell suspensions» Following 
^Blosonic II. Bronwlll Scientific Co., Rochester, New 
York» 
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disruptionp the suspension was washed three times in PBS-7 
and the walls were sedimented by centrifugation at 5,000 g 
for 30 minutes at 4 C, The walls were resuspended in k 
volumes of PBS-7, treated with ribonuclease^ (10 ug/ml) 
for 4 hours at 37 C, washed twice with PBS-7 at 5,000 g and 
resuspended at a concentration of 25 per cent in PBS-7» 
The cell walls were extracted with acid according to the 
usual procedures, centrifuged, neutralized with N/5 NaOH 
in M/15 phosphate buffer and pooled. 
Fractionation of the pooled, supernatant fluids was 
done with 33 to 60 per cent ammonium sulfate,^ Initially, 
17 grams of ammonium sulfate was slowly dissolved in each 
100 ml of supernatant fluids and the mixture was allowed 
to stand at room temperature over night. The resulting 
precipitate was removed by centrifugation at 17,000 g for 
30 minutes at 4 C and discarded. The supernatant fluid 
was adjusted to pH 8,0 with 1 N NaOH and brought to 60 per 
cent saturation by adding 13=9 grams of ammonium sulfate per 
100 ml. This solution was mechanically stirred for lo5 hours 
at 4 C and then centrifuged at 1?.000 g for 30 minutes at 
^Worthington Biochemical Corporation, Freehold, New 
Jersey, 
2 J, T, Baker Chemical Co., Phllllpsburg, New Jersey, 
76 
k C, The 33 to 60 per cent pellet was solubillzed in 
distilled water and dialyzed against PBS-7 for 18 hours 
at 4 C, This material was used for antigen analysis and 
protection tests in mice and swinee 
Purified type specific antigen 
The partially purified antigen was thawed» protein 
content determined by Lowry's method (28?), and 50 mg (dry 
weight) of the 33 to 60 per cent pellet, was layered onto 
a carboxjrmethyl cellulose column (CMC),^ equilibrated with 
0,03 M sodium acetate» Elutlon was performed according to 
procedures developed by Pox (146), Five ml samples were 
collected with a fraction collector and the effluent was 
monitored with an ultraviolet analyzer^ at 280 nm with a 
3 mm optical path. The column flow rate was regulated to 0,5 
to 1,0 ml/min by means of a peristalic pump,^ The pH and 
In/ absorption of each saiapls tîas scnltcrsd and rscordsd, 
Elutlon was begun at tube 1 with 0«1 M sodium acetate 
buffer pH 5,5. When the effluent reached pH 5»5? a three 
chambered gradient elutlon was initiated; 75 ml of 0,1 M 
potassium phosphate buffer at pH 6,0, 75 ml at pH 6=5 and 
^BioRad Laboratories, New York, New York, 
^Instrumentation Specialities Company, Lincoln, 
Nebraska, 
^LKB Instruments Inc., Rockville, Maryland, 
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200 ml at pH 7,0. The elution was continued until the 
effluent reached pH 7»0, After fractionation, each peak 
was lyophllized, reconstituted in a small amount of PBS-7 
and dlalyzed against PBS-7 for 18 hours at 4 C. After 
dialysis, the samples were evaluated by immunodiffusion 
and those containing type-specific antigen were saved for 
further evaluation. 
Type-specific antigen was separated from crude sonicate 
by a modification of the method used with the partially 
purified acid extracts of cell walls. Prior to chromatog­
raphy on CMC, the crude sonicate was dlalyzed for 2 days 
at 4 C against 4 changes of phosphate buffered saline 
prepared with sodium Instead of the potassium salts. 
Serological Evaluation 
Streptococcal cells utilised for hyperlmmunlzatlon of 
rabbits and swine were harvested from 16 to 18 hour THE 
cultures# The cells were centrlfuged, washed once in PBS-7 
and resuspended In PBS-7 at a concentration of 3 x 10^ CPU 
per ml. Sodium merthlolate^ was added to a final concen­
tration of 1(10,000, The suspension was incubated for 12 
^Ell Lilly and Co., Indianapolis, Indiana, 
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to 24 hours at 37 C and then examined for viability and 
purity before storing at 4 C, 
New Zealand rabbits, which had been determined to be 
negative for 3, equisimilis antibodies by Indirect hemagglu­
tination and capillary precipitation procedures, were given 
a series of 6 Intravenous (IV) Injections of merthiolate 
killed whole cells (1, 2, 2, 4, k and 10 billion) at 3 day 
intervals. Ten days after the last injection, all rabbits 
were test bled and given another IV injection of 10 billion 
cells. Ten days later they were exsanguinated by cardiac 
puncture and the serums were harvested and stored at -20 C, 
Serum was heated at $6 C for 30 minutes prior to use in CP 
or IHA procedures. 
Hyperimmune swine serums were prepared from colostrum-
deprived swine which had been immunized according to the 
above protocol. Epinephrine^ (0,5 ml) was adminlstred IV 
with each injection to prevent shock. For exsanguination, 
the swine were anesthetized with CO2 and the axillary and 
Jugular blood vessels were severed» Serums were harvested 
and stored at -20 C. Prior to use In a serological test* 
serums were heated at 56 C for 30 minutes. 
^Blanco Products Company, Indianapolis, Indiana 
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Immimoeleotrophogesis 
Imunoelectrophoresis was don® on microscope slides 
coated with 1 per cent lonagar #2^ In 0*05 M barbital buffer 
at pH 8.6. Electrophoresis was performed for 2 hours at 
5 Tolts per cm. Commercial goat anti-whole swine serum 
and goat antl-swlne IgG^ were used to Identify Immunoglobulin 
3 
classes of fractionated serums.'^ 
Gel electrophoresis 
Polyacrylamlde gel electrophoresis was conducted ac­
cording to the method of Hazln and Botte© (372) with a 
slight modification. Approximately l^J-O u liters of antigen 
solutionp either hot acid, sonle-derlved or purified type-
specific® with a protein content of approsimately 150 ug of 
protein vas applied to each tube. Electrophoresis was carried 
out in 7»5 P@r cent gel with a cationlo system at room temper­
ature for 3 hours at a constant current of 3»5 millianps per 
1 ^ gel. 
PrQolpitation 
Precipitation tests were carried out according to the 
method of Swift et al, (^63). 
1Consolidated Laboratories, Inc., Chicago Heights, 
IllinoiSo 
^Miles Laboratories, Kankakee, Illinois. 
3m, Le Hubbard, Ames, lows. Immunoglobulin Classes, 
Private Communicationj 1972. 
^A, P. Omlng, Ames, Iowa. Electrophoresis. Private 
Communication, 1972. 
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ImmuKodlffusion 
Immunodiffusion was done in petri plates prepared with 
0,5 per cent lonagar #2 in distilled water that contained 
1 per cent sodium azide and 0,85 per cent NaCl, Wells 
were approximately 6,0 mm apart and 6 mm in diameter and 
were filled with 0,1 ml of an appropriate antigen or anti­
serum. The plates were incubated at room temperature for 
48 hours in a moist chamber. 
Gel filtration 
Gel filtration using Sephadex G-200^ was done following 
the methods described by Flodin and Killander (1441, Serums 
from placebo and vaccinated swine and rabbits were passed 
through a Sephadex 0-200 column which was prepared in tris-
buffer. 
To prepare the trls-buffer, 66 ml of 0,5 M HCl was 
added to 133: mis of 0.5 M trls^ stock solution at room 
temperature and made up to one liter with 0,1 M NaCl, The 
pH of the buffer was BoO, A PharBacla K15/90^ column was used® 
Inactivated serums were applied in 0,5 ml volumes, eluted 
at a rate of 10 to 12 ml/hour and collected in 5 ml samples, 
^Fischer Scientific Co,, Pair Lawn, New Jersey, 
^Pharmacia Fine Chemicals Inc.* Plsoataway, New Jersey, 
^Nutritional Biochemical Corp., Cleveland, Ohio. 
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Optical density was determined at 280 nm with an ultraviolet 
analyzer.1 Three fractions from each of the first 3 peaks 
were pooled and concentrated by placing the solution in a 
2 dialysis bag and passing a stream of air over it. The CF 
and IHA streptococcal antibody content of each pool was 
determined. The predominant imunoglobulin class of each 
pool was determined by Immunoelectrophoresis. 
Starch block electrophoresis 
A starch block (36 i 10 z l,k cm), containing '400 grams 
of purified potato starch^ mixed with 100 mis potassium 
phosphate buffer « pE 6.2 and 0,023 M ionic strength, was pre­
pared. Antigen to be electrophoresed was mised with 5 grama 
of starch and placed in a 1 % 6 z 9 oa well cut out of the 
center of the block. Electrophoresis was carried out in the 
cold (4 C) for 4o hours at 5 to 10 mllliamps and 100 volts. 
At the end of the run, the starch block was cut into 18 two on 
strips, starting with the negative pole and each was extracted 
with 10 ml of phosphate buffeg. The estraets were eonoen-
trated 10 fold by pervaporation® Total protein content was 
^Instrumentation Specialities Co,, Lincoln, Nebraska. 
^Union Carbide Corp,, Chicago, Illinois. 
^Fischer Scientific Co., Fair lawn, Hew Jersey. 
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determined by Lowry's method (28?) and the samples were 
evaluated for serological activity by Immunodiffusion. 
Samples were also evaluated for their ability to elicit 
protection in mice. 
Complement-fixation 
Sheep red blood cells (SRBC) were collected 7 to 1'4 
days prior to use in Alsevers solution (l6l) and held at 
(4' C, Immediately prior to use, cell suspensions were 
mixed with 3 volumes of cold IX veronal buffer (VBD) and 
the material was centrlfuged at 600 g for 5 minutes at 4 C« 
Supernatant fluids were removed along with the buffy white 
cell layer and the sedimented red cells were mixed with 
cold VBD. The SRBC were washed 2 additional times with 
cold VBD and resuspended in VBD to make a 2.8 per cent 
volume to volume suspension (1 volume packed cells to 34*7 
volumes VBD)« The 2.8 per cent SRBC suspension was diluted 
is 10 with VBD to obtain a 0.28 per cent suspension. This 
material was combined with an equal volume of VBD con­
taining rabbit hemolysin" (1:500), 
Two fold dilutions of inactivated serum were prepared 
in VBD using microtiter plates^ and diluters«3 0.025 ml 
iDlfoo Laboratories, Detroit, Michigan. 
"Llnbro Scientific Co., Inc., New Haven, Connecticut, 
^Cooke Engineering Co., San Mateo, California, 
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of an appropriate antigen dilution was added to each of 
the serum dilutions as well as two wells devoid of antiserum. 
Serum controls were also maintained free of antigen, Lyoph-
ilized guinea pig complement^ was reconstituted with normal 
serum from a 6 to 8 week old pig. In this way the procom-
plementary effect of swine serum was accounted for in the 
titration of guinea pig complements 0,05 of complement 
containing 5 hemolytic units» was added to each microtlter 
well. The plates were shaken for 2 minutes on a vibrator»^ 
left at 4 C overnights removed from the cooler the following 
day and 0,025 ml of sensitized SRBC was added to each micro­
tlter well. The plates were shaken for 30 seconds, placed 
at 37 C for 30 minutes» removed and the reciprocal of the 
highest dilution demonstrating less than 30 per cent hemo­
lysis was recorded (l6l). 
Hemagglutination 
Sheep red blood cells (SHBC) were collected 3 to 5 days 
before use in an equal volume of Âlsevers solution (loi) 
and held at 4 C, Immediately prior to use, the cells were 
sedimented at 500 g for 5 minutes at 4 C. Packed cells 
were resuspsnded in 15 volumes of PBS=7«55 and washed 3 
^Grand Island Biological Co., Grand Island, New York, 
? 
A, H. Thomas Co., Philadelphia, Pennsylvania. 
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times. Following the final mash, the cells were resuspended 
in PBS-?,55 to a 5 per cent v/v concentration. The cells 
were warmed to 37 C and an equal volume of prewarmed, 
freshly prepared tannic acld^ (1:10,000) was added. The 
mixture was shaken in a 37 C water bath for 15 minutes and 
centrifuged at 400 g for 10 minuteso The cells were washed 
once and resuspended to 5 per cent in warm PBS-7,55» 
A 15 ml amount of tanned cells was added to an equal 
volume of PB8-7.55 solution containing an optimal concentra­
tion of antigen. This misture was incubated in a 37 
C water bath for 45 minutes with occasional shaking. Sensi­
tized cells were centrifuged at 400 g for 5 minutes and 
washed twice in warm PB8-7»55 containing normal rabbit 
serum (1:150). Centrifugatlon for each wash was 10 minutes 
at 400 g9 The sensitized cells were resuspended in warm, 
PBS-7,55 {containing normal rabbit serum Is100) to an approz-
Imate 0,5 per cent concentration. 
Two fold dilutions of serums were prepared in microtiter 
plates with PBS-7o55 and 1*100 normal rabbit serum, 0,025 ml 
of the sensitized SRBC solution was added to each well. The 
plates were sealed with transparent tape, shaken for 2 minutes 
^Mallinckrodt Chemical Works, St, Louis, Missouri, 
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and refrigerated overnight at ^  C, Results were recorded 
the following morning. 
When hemagglutination occurred, the sensitized red blood 
cells settled out as a shield on the bottom of each well. 
Lack of agglutination was indicated by formation of a small 
dense button of cells in the center of the well* The titer 
of a serum was recorded as the reciprocal of the highest 
dilution with complete agglutination. 
Challenge 
One vial of lyophilized culture was reconstituted with 
sterile distilled water and inoculated onto 5 per cent horse 
blood agar plates. Following incubation for 18 hours, one 
typical S8 equisimilis colony was picked to THBj the culture 
was incubated at 37 C for 18 hours and examined mleroseopi-
cally for purity. Pour drops of the 18 hour culture were 
transferred to 10 ml of pre-warmed THB® This culture was 
incubated for 6 hours at 37 C and examined for purity» Cell 
numbers were estimated by optical density and viability 
determined by plate count» Growth under these conditions 
usually resulted in viability counts between 2 and 8 x 10® 
CPU per mlo This material was diluted IslOO in 1 per cent 
neopeptone^ before use in swine and mice. 
^Difeo Laboratories, Detroit, Michigan, 
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Mouse Experiments 
Inbred 3 week old Swiss-Webster mlce^ were used in these 
experiments. The animals were housed in plastic boxes with 
no more than 5 animals per cage and given water and a cornier-
p 
cial ration free choice. 
Mice were held for 4 days following receipt from the 
supplier before use. Equal numbers of males and females were 
allotted to each group. The animals received two 0,25 ml 
doses of streptococcal antigen administered subcutaneously 
at 7 day intervals. Ten days after the last inoculation, 
vaccinated and control mice were challenged. 
Mice were challenged with 0,25 ml of a 6 hour culture 
produced according to the procedure described previously. 
The challenge dose was administered intraperltoneally 
followed immediately by 0,15 ml of a 5 per cent gastric 
mucin solution. Death resulted within 48 to 96 hours in 
non-vaccinated mice. 
Swine Experiments 
Active and passive protection tests were done In young 
colostrum-deprived, surgically-derived or occasionally in 
^ARS/Sprague Dewlany, Inc,, Madison, Wisconsin, 
^Lab bloCç Allied Mills Inc,s Chicago, Illinois, 
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young naturally-bom swine. Sows were of Yorkshire, Bamp-
shire or cross-bred Yorkshire-Hampshire breeding mated to 
Yorkshire or Hampshire boars. They were procured shortly 
before farrowing from local farmers or from a herd maintained 
1 
at the Veterinary Medical Research Institute, 
Pigs were obtained by Caesarean section when the sows 
evidenced mammary gland and other changes indicative of Im-
pendlng parturition. The pigs were removed aseptically» 
passed to a sterile room, wiped with sterile paper towels, 
and the umbilical cords were ligated, severed 2 to 3 cm from 
the abdominal wall and dipped in tincture of iodine. The 
animals were transferred to individual cardboard bozes or pens 
and maintained in an isolation unit at 92 to 96 F. They were 
initially fed 2 to 3 ounces of SPP-lao^ four times per day 
with gradual Increases in amount of SPP-lac depending on the 
appetite and health of the pigs. After 7 to 10 days the pigs 
were grouped according to size and fed about ^ to 8 ounces per 
feeding for the next two to three weeks, When the pigs were 
2 to 3 weeks of age a complete 18 per cent protein pig 
starter and water were offered free choice. When the pigs 
^Veterinary Medical Research Institute, Iowa State 
University, Ames, Iowa, 
^Borden Company, New York* New York 
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were eating the starter well, the SPP-lac was gradually 
decreased in amount so that they were weaned by 4 to 5 
weeks of age. 
Streptococcal vaccine for use in swine consisted of 
antigen and adjuvant^ which was mixed until a water-in-oil 
emulsion was achieved. The prepared vaccine was held at 
4 C until usedo It was administered in a series of 3 
doses consisting of 2 ml inoculations given intramuscu­
larly at 4 day intervals. 
All swine used in this study were CP and IHA negative 
for detectable levels of antibodies against S, equisimilis 
at the time of initial inoculation. 
Swine were challenged with 1 ml of the diluted 6 hour 
culture, usually administered Into the marginal ear vein. 
Following challenge, swine generally evidenced elevated 
temperatures within 24 hours and lameness within 24 to 48 
hours. Other clinical signs observed in some but not all 
challenged animals included roughened hair coats, joint 
swelling and inappetence. Joint involvement was frequently 
the most obvious symptom. 
Four or five days postchallenge, the pigs were elec­
trocuted and exsanguinated by severance of the brachial 
^Incomplete t'reund, Dlfco Laboratories, Detroit, 
Michigan» 
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blood vessels. All limb joints, as well as liver, kidney, 
spleen and heart were examined for gross lesions. All 
joints and organs were seared on the exterior and opened 
by making an incision with a heat-sterilized knife. Samples 
were routinely collected from all joints and tissues with 
sterile cotton swabs^ and Inoculated onto 5 per cent horse 
blood agar plates which were incubated 24 to 48 hours at 
37 C, Following Isolation of the organism, biochemical 
and serological identification was done as described 
previously. 
Sites inoculated with vaccine were routinely examined 
for gross evidence of abscesses and any other untoward 
reactions» 
^American Hospital Supply Corpos McGraw Park, Illinois* 
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RESULTS 
Cultural and Bloohemloal Characteristics of 
Streptococcal Strains 
Zones of beta hemolysis on blood agar were comparable 
for all strains of S. equisimilia. although strain 78-A3X 
had a slightly larger zone (Figure 1). The zones averaged 
to 6 mm in diameter at 2^ hours incubation and did not 
increase significantly after an additional Zh hours. All 
5 strains fermented dextrose, lactose, sucrose and trehalose 
within Z^ hours and glycerol between 24 and 48 hours incu­
bation, Strains F-49 and 78-B were sallein positive, while 
the other 3 were negative, Mannltol, sorbitol and raffinds© 
were not fermented, S, zooepidemlcus fermented lactose, 
sucroseg sallcin and sorbitol but not the other sugars. 
Strain 9932 fermsntsd dsstross, lactose, sucrose, glycerol 
and trehalose but not salloln, mannitol, sorbitol or raff-
Inose, Growth in broth cultures generally tended to be 
relatively smooth and diffuse, although strains 78-A3X, 
B-8 and 9932 occasionally formed sediment. 
All streptococcal strains used in this study, except 
9932, were shown to belong to Lanoafield Group C# Strain 
9932 reacted with Lancefleld Group L antiserum. The sero­
type specificities of the S, equlslmllis strains are 
presented in Table 1 along with bloohemloal and sero-
grouping results. 
Figure i, streptocoscug equlsimilis 
a. Strain 78»A3X gromi Zk hours on 
blood agar. 
bo Strain 78-A grown 24- hours on 
blood agar. 
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Table 1, Biochemical and serological characteristics of streptococcal cultures. 
Serological 
Carbohydrate Fermentation Lance- S. eaui-
field Similis 
strain Dez.^ Lao. Suc» Sal, Man. Gly. Sor« Raf. Treh. Groupé type*^ 
Se j^ulsigills 78-A A^ A A neg® neg A neg neg A C I 
A A A neg neg A neg neg A c I 
J® equlsimllls R-8 A A A neg neg A neg neg A c II 
A A A A neg A neg neg A c III 
8« equislmilis A A A. A neg A neg neg A c IV 
Se zooepidemicus ne g A A A neg neg A neg neg c N.D.f 
Group L 9932 A A N,D« neg neg A neg neg A L N.Do 
®DeXo = dextrose f Lac«=lactose ; Sue « ^ sucrose ; Sal«=sallcln» Man,=niannitol » 
Glye=glycerol5 Sor.^sorbitol; Haf,=:raffinosej Treh.=trehalose® 
^Group determined by capillary precipitin test, 
^Serotype determined by iamunodiffusion, 
^Acld produced, 
®No acid produced, 
^Not determined» 
9i^ 
Swine-passaged strain 78-A3X was biochemically« sero­
logically and microscopically indistinguishable from parent 
strain 78-A. However, strain 78»A3X appeared to produce 
slightly larger colonies on blood agar with a larger zone 
of beta hemolysis (Figure 1). Todd-Hewitt broth cultures 
of 78-A3X frequently had clear supernatants and a grainy 
sediment J whereas cultures of the parent strain remained 
fairly diffuse with less sediment. 
Swine-passaged strain 78-A3X was more virulent for 
mice and swine than strain 78-A, Strain 78-A3X had an 
LD50 of 4 z 10^ CPU for mice (Table 2), whereas strain 
78-A had an LD50 of 5 x 10^ CPU (Table 3). In swine, 78-A3X 
had an arthritic dose 50 of ^  x 10^ CPU (Table 4), whereas 
strain 78-A had been shown previously (2^5) to have an 
arthritic dose 50 of 7.2 z 10® CPU, No appreciable differ­
ence was detected in the serological response of swine to 
the two strains, 
Complement-Pixation and Hemagglutination 
Comparison of non-adsorbed antiserums prepared in 
rabbits against 4 different serotypes of S, equleiallis with 
the CP procedure revealed some evidence of serotype sped-
ficity (Table 5)f however, relatively high levels of cross 
reacting antibodies were often detected. Multiple absorption 
procedures eliminated most of the cross^reactive antibodies 
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Table 2, Pathogenicity of 8, equlslmllls 78-A3X for mice» 
Group 
Number of CPU 
Inoculated/Animal® 
Survivors/îotal 
Challenged 
1 2 X 10® 0/25 
2 2 X 10? 0/25 
3 2 z 106 3/25 
Ur 2 X 10^ 5/25 
5 2 X 10^ 8/25 
6 2 X 103 12/25 
7 2 X 102 22/25 
8 2 X lOl 23/25 
9 Placebo^ 25/25 
&Mlce were challenged subcutaneously with 0,25 ml 
of suspension containing appropriate number of CPU as 
dstsnsinsd by actual plats count® 0»Î5 ml of a 5 pe^ 
cent gastric mucin solution was inoculated Intraperi-
toneally at the time of challengee Deaths were recorded 
for 7 days, 
^Todd-Hewitt broth diluted 1*10 with 1 per cent 
neopeptone. 
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Table 3» Pathogenicity of S. eQUislmllis 78-A for mice. 
Number of CPU Survivors/Total 
Grdup Inoculated/Animal^ Challenged 
1 1.6  X 10® 0/20 
2 1,6 X lo7 3/20 
3 1.6 X lo6 12/20 
4 1.6  X 103 18/20 
5 1,6 X 10^ 18/20 
6 1.6  X lo3 17/20 
7 1,6 X 10^ 18/20 
8 1,6 X 10^ 20/20 
9 Placebo^ 20/20 
"Mice were challenged subcutaneously with 0.25 ml 
of suspension containing appropriate number of CPU as 
determined by actual plate count, 0,15 ml of a 5 per 
cent gastric mucin solution was inoculated intraperi-
toneally at the time of challenge » Deaths were recorded 
for 7 days. 
^Todd-Hewitt broth diluted IslO with 1 per cent 
neopeptone. 
Table k-. Pathogenicity of S, equi«imills 78~A3X for 3 week old CDCD swine. 
Evaluation of Response 
Noe Joints ~ 
Number Number of CPU Lameness No, Joints Positive for S, 
Group Pigs Inoculated/Animal Index® with Lesions® equlsimillsQ 
1 3 2.05 X 107d 0.31 12/36 11/36 
2 £|, 3,65 X lo6 0.25 27/48 20/48 
3 3 2.05 X lo6 0.20 7/36 8/36 
4 4 3.65 X lo5 0.27 19/48 15/48 
5 3 2.05 X 10-5 0.12 8/36 11/36 
6 4 3.65 X 10^ 0.33 28/48 23/48 
7 3 2.05 z 10^ 0.08 9/36 5/36 
^Lameness index=Totsl number of limbs exhibiting lameness during 5 days 
postchallenge divided by total observations. 
^Total number of arthritic joints over total number of joints observed 
at necropsy 5 days postchalleng©» 
®Total number of joints containing S. equisimilis over total number 
of joints cultured at necropsy 5 days postchailehge. 
^Number of CPU based on actual plate count. 
Table 5« Comparison of four serotypes of Streptooocous equlslmllls by 
complement-fixation» 
Non-adsorbed rabbit antiserums 
Antigen Preparations 
Serotype I 
78-A 
Serotype II 
R-8 
Serotype III 
78-B 
Serotype 
F-49 
® 320^ 160 160 40 
S« equlslmllls 78-A 8D° 6(4.0 80 80 80 
S« ©quislmills R-8 SCI k'O 2560 320 40 
§.* ®quisimilis R-8 SD k'O 1280 320 40 
So ©quislmills 78-B HCl 20 ïfrO 2560 320 
S, equlmlmills 78-B SD 20 160 2560 320 
S» equlslmllls P=^9 HCl 20 160 160 320 
8. eauisimilis F-M-Ç SD 20 80 20 640 
Se sooepldemlcus HC'l 10 «fO 20 20 
S« zooepldemicus SD 10 40 20 20 
Group L 9932 HCl <10 «10 80 80 
Group L 9932 SD <10 20 40 80 
^Conventional hot acid extract» 
^Heclprocal titer determined by duplicate block titration. 
®Sonic derived extract centri.fuged at 30,000 g« 
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but required considerable time and streptococcal cells. 
Representative titers obtained with adsorbed and non-adsorbed 
hyperimmune swine and rabbit serums, as evaluated by CP and 
I HA, are presented In Table 6, Purified hot acid extract 
from serotype 1 reacted by CP with its homologous antiserum 
but failed to react with other 8. equislmllls antiserums 
(Table 7)« The purified serotype I antigen was not evaluated 
with the IHA procedure. 
Comparison of various S, eguisimllis preparations indi­
cated that supernatant from sonically disrupted cells (SD 
30,000 g) was the most potent CP antigen and that it re­
sulted in minimal non-specific hemolysis and anticomplemen­
tary activity (Table 8). The SD 30,000 g procedure resulted 
in a CP antigen yield approximately 180 times greater, on 
a per cell basis, than that obtained by extraction with 
hot acid. In addition, the optimally diluted SD 30,000 g 
preparation reacted at a 4 fold higher dilution of a standard 
swine antiserum than did hot acid extract. 
Immunodiffusion (ID) analysis revealed that SD 30,000 g 
and SD 3,000 g preparations of strain 78=A3X contained at 
least 3 separate precipitating antigens when evaluated 
against a homologous, non-adsorbed rabbit antiserum (Pigure 
2). Hot acid extracts derived from S. eguisimllis R-8 
(serotype II) and 3» zooepidemicus shared one precipitating 
Table 6, Effect of whole cell absorption on complement-
fixing and indirect hemagglutinatlng antibody 
titers of hyperimmune serums. 
Complement-Fisation^ 
Antiserums Ron-AdsorbedK Adsorbed^ 
Sero- Homo- Hetero- Homo- Hetero-
Number^l Source type logous® logons^ logous logous 
5 Swine I 640 160 320 <10 
8 Swine I 160 80 80 <10 
128 Rabbit I 40,960 1,280 10,240 <10 
129 Rabbit II 5,120 320 2,560 10 
137 Rabbit III 2,560 160 640 10 
153 Rabbit I 5,120 2,560 1,280 <10 
218 Rabbit I 5,120 1,280 2,560 <10 
^Reciprocal homologous CP and IHÂ titers determined 
by duplicate block titrations, 
%cn=adscrbsd sntlssroiss heat Inactivated for 30 
minutes at 5^ C. 
°Type-specific antiserums prepared by multiple whole 
cell absorptions. Serums inactivated at $6 C for 30 minutes. 
^Immunizing antigen: numbers 5S 8? 128 and 153 were 
S, e.qul simili s 78-A? 218 was S, equisimilis ?8-A3XÎ 129 was 
S« equisimilis R-8; and 137 was S, equisimilis 78-B, 
®Test antigens were sonicates of the respective immu­
nizing antigens (Column 1). 
^Test antigen was sonicate of S. equisimilis R-8 
(serotype II) when testing animals immunized with S, 
equisimilis 78-A or 78-A3X and sonicate of S, equisimilis 
7o-A (serotype 1) when testing animal immunized against 
S. equisimilis R-8, 
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Indirect HemaK%lutlnatlon& 
Non-aàsorbedt^ Adsorbed^ 
Homo- Hetero- Homo- Hetero-
logous lOKOUS lOKOUS lOKOUS 
512 512 128 8 
128 64 64 16 
8,192 2,048 2,048 16 
512 256 256 8 
1,024 512 256 4 
512 128 128 8 
2,048 512 512 ^4 
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Table 7. Comparison of crude hot acid extract and puri­
fied serotype I antigen from S. eguisiailis 
78-A3X by ©omplement-flzationT 
Non-adsorbed rabbit antiserums 
8ero= Sero­ Sero= Sero=» 
Antigen type I type II type III type IV 
Preparation 78.A3I B-8 78-B F-49 
Crude hot 
1280* Acid estraot 320 40 160 
Purified sero­
type I 
640 antigen 410 <10 <10 
^Reciprocal titer determined, by duplicate block 
titrations. 
antigen Hith strain 78»A3X that Has probably the Group 
C carbohydrate. Other antigens demonstrated by ID in hot 
acid and SD preparations of S. equisiailis 78-A3X were a 
non-type-specific antigen and the S. equisiailis serotype 
I antigen. Precipitating antigens cross-reactive with 
S» egUlbIeIIIs SêrOtypô X âïifelSerwSî ëcZB îîOt dstsstêd iîî 
a hot acid extract of the Group L strain. 
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Table 8, Potency of complement-fixing antigen in various 
preparations of S, equlslmllls 78-A.  
Preparation 
Optimal Dilution for 
Maximal Sensitivity 
Working^ Actual^ 
Dilution Dilution 
Reciprocal 
Serum 
Titer© 
Acid extracted 
whole cells 16 32 320 
Acid extracted 
cell walls 8 16 320 
Alkaline extracted 
whole cells 2 8 320 
3D 3,000 gd 8 1240 320 
SD 30,000 g 32 3760 1280 
SD 100,000 g 32 5760 1280 
^Reciprocal of dilution of each preparation which gave 
the highest titer in a block titration with a standard 
antiserum® 
^Relative potency of each preparation. Determined by 
combining the working dilution factor with the dilution re­
sulting during preparation of the extract from packed cells, 
^Non-adsorbed, homologous swine serum. 
^•Sonlcally disrupted and oent-rifuged at 3*000 g ,  
30,000 g or 100,000 g» 
104-105 
Post Immunization serums of 6 swine exhibited a 
sequential rise in CP antibodies against S» equisimilis 
78-A when compared to the pre-immunization serums. The 
geometric mean titer (GMT) of CP antibody was <10 on day 
0, 4o on day 14 (3 inoculations) and 26? on day 35 (8 inoc­
ulations). The GMT of IHA antibodies in these same serums 
was 44 on day 0, 12 on day 14 and 48 on day 35. None of 
the serums collected from 4 placebo vaccinates contained 
antibodies detectable with either CP or IHA procedures. 
Fractionation of Streptococcal Antigens 
Gel filtration 
A 20 mg sample of S, equisimilis 78-A3X hot acid extract 
was applied to a Sephadex G-200 column and forty 5 ml samples 
were collected. Immunodiffusion (ID) analysis indicated 
that samples 14 through 34 contained streptococcal precip= 
itating antigens. The group polysaccharide antigen was 
demonstrated in all samples that contained precipitating 
componentse 3y use of type-specific antiserum in an ID 
test, the type-specific antigen was located in samples 15 
through 21, Mouse protective activity was distributed 
throughout the eluate (Table 9)» Similar results were 
obtained when 25 or 30 mg of hot acid extract or 30 mg 
of sonic extract were applied to the columns although 
mouse protective activity was not observed. 
Figure 2, Immunodiffusion analysis of hot acid and sonic 
extracts. Well AS contained non-adsorbed 
rabbit antiserum against 8, equisimilis 78-A 
(serotype 1)J well 1 contained hot acid extract 
of S, equisimilis 78-A, well 2 contained a SD 
30,000 g extract of 8, equisimilis 78-A, well 
3 contained a SD 3,000 g extract of 8, equisi­
milis 78-A, well 4 contained a hot acid extract 
of 3« eoui simili s R-8 (serotype 11)* vrell 5 
contained a hot acid extract of S, zooepidemicus 
and well 6 contained a hot acid Extract of 
Group L 9932. 
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Table 9« Analysis of fractions of S» equlsimilis hot acid and sonic extracts 
eluted from Sephadex G~2:00. 
Hot Acid Extract 
30 mg Sonic Extract (30 mg) 
Type- Type- Type 
Group C Specific Mouse Group C Specific Mouse Group C Specific Mouse 
Sample Anti- Anti- Protec- Anti- Anti- Protec- Anti- Anti- Protec-
Number®- serum^ serunC tion"^ serum serum tion serum serum tion 
1 -f® 10 + 4- Fooled + -
Samples 
2 4- 4- 80 + +1 to 7 + + Pooled 
30^ Samples 
3 + + 70 + + + 2 to 11 
30^ 
 ^ + *4- oO + 4" 
®Pirst sample eluted containing at least 1 precipitating antigen, 
^Immunodiffusion analysis of samples against non-adsorbed antiserum, 
°Immunodiffusion analysis of samples against type-specific antiserum, 
^To determine mouse p3POtection, 10 mice were vaccinated with two 0.25 ml 
doses of each sample subcutaneously on days 0 and 7» The mice were challenged 
subcutaneously 14 days later with approximately 4 x 10° CPU of S, equlsimilis. 
0,15 ml of a 5 per cent gastric mucin solution was injected simultaneously» ' 
Deaths were recorded for 5 days, Protection expressed as survivors/total 
challenged X100$, 
®Presence of at least one band in immunodiffusion, 
^Absence of any precipitating bands In immunodiffusion. 
Table 9.(continued) 
Hot Acid Eîctract 
20 mg 30 mg Sonic Extract (30 mg) 
Type- Type- Type 
Group C Specific House Grroup C Specific Mouse Group C Specific Mouse 
Sample Anti­ Anti­ Protec­ Anti­ Anti­ Protec­ Anti­ Anti­ Protec­
Number^ serum^ serum® tion^ serum serum tion serum serum tion 
5 4- 4' 40 + + + + 
6 4- 4' 40 + + + + 
7 + 4 60 4- + + + 
8 + 4' 60 + Pooled + + 
Samples 
9 •f 60 + M 8 to 16 + 
10# 
10 + 
— 
NSS + - + + 
11 + " 20 + — + + 
12 + 6o + + Pooled 
Samples 
13 + 20 + ax* + •0» 12 to 18 
30 ^  
14 + es 20 + «M + •» 
SNo sample « 
Table 9. (continued) 
Hot Acid Extract 
20 m# 30 m« Sonic Extract (30 mp:) 
Type- Type- Type-
Group C Specific Mouse Group G Specific Mouse Group C Specific Mouse 
Sample Anti­ Antl- Protec­ Anti­ Anti­ Protec­ Anti­ Anti­ Protec­
Number^ serum^ serum® tion^ serum serum tion serum serum tion 
15 + .» 20 + + » 
16 + 60 4- « + 
1? + 60 Pooled + 
Sample s 
18 + — 20 - « 1? to 22 + — 
19 4- (•» 80 ea + Pooled 
Samples 
20 + «» 20 SB mm OB 19 to 22 
0% 
21 + 20 — + — 
22 NS •• + oa 
t-* 
o 
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starch block electrophoresis (SBE) 
Electrophoresis of sonic (Figure 3) and hot acid 
extracted antigens in starch produced similar patterns. 
Precipitating streptococcal antigens were present in elec-
trophoresed sonic extract samples 6 through l4 when evalu­
ated against non-adsorbed hyperimmune serum (Figure 4) 
and samples 7 through 13 when evaluated against type-specifi© 
rabbit antiserum (Figure 5)« Immunodiffusion analysis of 
electrophoresed hot acid extract indicated that precipita­
ting streptococcal antigens were present in samples 5 through 
IW- and the type-specific antigen was located in samples 7 
through 13; the separation pattern was identical to that 
obtained for the sonic extract. Mouse protection appeared to 
be related to those fractions containing the type-specific 
antigen (Figure 3), 
Gairuôïyméthyl ûêllulwâê (CHC) 
The slution profile of a hot acid extract resulting fros 
chromatography on CMC is shoTîn in Figure 6. Similar findings 
with a sonic extract are shown In Figure 7. Samples of peak 
1, peak 2 and peak 3 were pooled and the pools pervaporated 
to 2 mis each. Immunodiffusion analysis of the pools indi­
cated that type-specific antigen was associated with the last 
two peaks. Peak 1 reacted with commercial Group C antiserum 
but failed to react tîith adsorbed, homologous type-speoiflo 
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antiserum. Pool 2 contained precipitating antigens reactive 
with both group and type-specific antiserum. A single band 
developed when pool 3 was used with type-specific antiserum 
or non-adsorbed homologous antiserum. It failed to react 
with commercial Group C antiserum or unadsorbed antiserum 
against other S. equlsimllis serotypes (Figures 8, 9), 
However, pool 3 contained 2 bands when electrophoresed in 
polyacrylamide, 
Gel Filtration of Normal and Hyperimmune Seruas 
Presented in Figures 10 and 11 are elution patterns 
of normal and hyperimmune swine serums following fraction­
ation in Sephades G-200. Elution profiles of normal and 
hyperimmune rabbit serums are presented in Figures 12 and 
13. As indicated on the figures, selected samples were 
pooled and the pools were pervaporated and analyzed, Dmu-
noelectrophoretic analysis indicated that peak 1 contained 
predominately IgM and that peak 2 contained predominately IgG« 
Serological evaluation of the pools Indicated most of the 
IHA antibody was present in the IgM fractions, whereas, the 
IgG frastion contained îscst of the CP antibody (Table 10)* 
Figure 3* Belationshij-p of total protein, mouse pro­
tective activity and the group and type-
specific antigens in samples from starch 
block electrophoresed S, equisiiailis 
78-A3X sonic extract. ""Arrow indicates 
point of application (cathode on left and 
anode on right). Immunodiffusion analysis 
used to locate group and type-specific 
antigens. To determine mouse protection, 
20 mice were vaccinated with two 0»25 ml 
doses of material from each sample. Four­
teen days later they were challenged sub-
cutaneously with S. equlslmilis 78-A3X. 
Deaths were recorded for 7 days: survivors/ 
total challenged XlOO^, 
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Figure 4, Immunodiffusion analysis of S. equisimilis 78-A 
sonic extract samples obtained by starch block 
electrophoresis. Sample 1 nearest cathode and 
sample 18 nearest anode. Center wells (153) 
contained homologous hyperimmune rabbit anti­
serum» HClshot acid extract from S, equisimilis 
78-A3X, 
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Figure 5. Immunodiffusion analysis of S, equisimilis 78-A 
sonic extract samples obtained by starch block 
electrophoresis. Sample 1 nearest cathode and 
sample 18 nearest anode. Center wells (153) 
contained homologous type-specific rabbit anti­
serum. HCl=hot acid extract from S, equisimilis 
78-A3X. " 
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Pisure 6, Chromatography of hot acid extract of S„ 
equlsimilis; 78-A3X on carboxymethyl cellulose. 
Pesik 1 consjisted of samples 3 through 6, peak 
2 consisted of samples 19 through 22 and peak 
3 consisted of samples 31 through 34, 
Peak 1 
0 . 6 0  
Protein 
Content S 0.50 
0.40 
<^0.30 
0 . 2 0  
.r 0.10 
CO.00 
Sam 
Peak 2 Peak 3 
20 25 
Number 
6.6 
6 . 0  
5.4 
4.8 
4.2 
3.6 
3.0 
Q. 
(U 
CL 
E fO 
CO 
Figure 7e Chromatography of sonic extract of equlsimllls 
78-A3X on carboxymethyl cellulose. Peak 1 con-
sisted of samples 3 through 6, Peak 2 consisted 
of samples 19 through 22 and peak 3 consisted of 
samples 31 through 3^» 
Peak Peak I 
Protein 
Content 
<D . 30 
15 20 
Sample Number 
Peak 3 
fv> N 
Figure 8. Stages in the purification of S. equisimllis 
serotype I antigen. Center well AS contained 
non-adsorbed rabbit antiserum against S. 
equisimllis 78-A3X, well 1 contained a~crude 
hot acid extract of S. equisimllis 78-A3X, well 
2 contained a hot sold extract of S, equisimllis 
78-Â3X after ammonium sulfate precipitation 
and well 3 contained purified type-speoific 
antigen from S, equisimllis 78-A3X. 
lig!» 
Figure 9» Specificity of purified serotype I antigen. 
Center well CMC contained purified serotype 
I antigen, well 1 contained rabbit antiserum 
against 8, equlsimills 78-A3X, well 2 contained 
rabbit antiserum against S. equlsimills R-8 
(serotype II), well 3 contained rabbit anti­
serum against S. equisiiailis 78-B (serotype 
III) and well ? contained rabbit antiserum 
against S, equlsimills F-49 (serotype IV)„ 
126 
Figure 108 Slution profile of Sephadex G-200 fractionated 
swine serum (7) before exposure to 8, equlsimllls. 
Peak 1 consisted of samples 6 through 9 and peak 
2 consisted of samples 12 through 16, 
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Piçure 11, Elutlon profile of Sephadex G-200 fractionated 
swine serum (?) following immunization against 
S. equisimilis 78-A (12 days post immunization). 
Pealc 1 consisted of samples 6 through 9 and 
peak 2 consisted of samples 16 through 18, 
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Figure 12» Elution profile of Sephadex G-200 fractionated 
normal rabbit serum (153) before S, equisimllis 
exposure. Peak 1 consisted of samples 3 through 
6 and peak 2 consisted of samples 11 through 14. 
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Figure 13, Elufcion profile of Sephadex G-200 fractionated 
rabbit serum (153) immunized against S, equl-
slmilis 78-A (21 days postImmunizationK 
%alc 1 consisted of samples 4 through 7 and 
Peak 2 consisted of samples 13 through 17« 
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Table 10. 
Serum 
Source 
Non-Vaccinated 
Swine 
Vaccinated 
Swine 
Non-Vaccinated 
Rabbit 
Vaccinated 
Rabbi t 
Non-Vaccinated 
Swine 
Peak I^edominant 
Ifumber^ Itamunoglobulin^ 
1 
1 
1 
1 
Ig M 
Ig M 
Ig M 
Ig M 
Ig G 
Complement-Fixation 
Reciprocal Titer® 
<10 
20 
<10 
40 
< 1 0  
Indirect 
Hemraagluti-
natlon Recip­
rocal Titer 
< 4 
128 
<4 
1024 
<4 
^Samples of psak 1 and samples of peak 2 were pooled, pools pervaporated 
analyzedo 
^Immunoglobulin class as demonstrated by Immunoelectrophoresis. 
^Reciprocal of homologous CP and IHA titers determined by duplicate block 
titrations® 
Table 10. (continued) 
Serum 
Source 
Vaccinated 
Swine 
Non-V ac c i nat e d 
Rabbi t 
Vaccinated 
Rabbit 
Peak Predominant 
Number®' Immunoglobulin^ 
2 
2 
Complement-Fixation 
Reciprocal Titer® 
Indirect 
Hemmaglutl-
natlon Recip­
rocal Titer 
Ig G 
Ig G 
Ig G 
160 
< 10 
640 
16 
< 4 
6^• 
137-138 
ImmujiQgenlcity of S, equislmills Antigens In Mice 
Comparisons of mouse protective activity of different 
S, equislmills antigen preparations are presented in Table 
11. The results listed in the table are a composite of 
several tests. Whole cell bacterlns were unable to elicit 
a high level of protection regardless of the inactivating 
agents Protection in whole cell vaccinates ranged up to 
60 per cent. Hot acid extract protected 80 per cent of 
vaccinated mice while hot alkaline extract protected 55 
per cent, A single dose of sonic vaccine protected 60 
per cent of those vaccinated whereas 2 doses protected 8? 
per cent. The addition of various inactivating agents to 
the crude preparation had little effect on mouse protection 
SD 30»000 g extract, which included most of the soluble 
components minus the cell wall, protected 72 per cent of 
vaccinated mice, Purified serotype I hot «ûlu êXtrâOt 
elicited protection in 90 per cent of vaccinated micee 
Placebo vaccinates were not protected against the challenge 
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Table 11. Immunogenlcity of Se equlsimilis 78-A3X 
preparations in mice. 
Number of CFU ^ 
Vaccine Treatment® Administered/Animal Protection® 
Heat-52® for 30 nin. 1.5 X lo9 60% 
b-propiolactone {3PL) 
109 33^ 0 .2# 1-5 X 
Merthiolate 1:10,000 1.5 X 10? 60^ 
Formalin (HCHO) 0.3# 1.5 X 10? 60$ 
Hot-acid 1 X lo l i  80^ 
Hot-alkaline 5 X IQIO 55^ 
Sonicated 1.5  X 10^ 87$ 
Sonicated 7.5  X 10® 60$ 
Sonicated-0,2^ BPL 1.5 X 109 85$ 
Sonicated-merthiolate 1.5 X 109 85$ 
^Cells obtained from 18 hour THB and resuspended in 
phosphate buffered saline at a concentration of 3 % lo9 CPU/ 
ral where appropriate and treated accordingly. 
^mmber of CPU based on actual colony count or estimated 
from packed cell volumes 1 ml of wet packed cells equals 
5.4 X loll CPU. 
°To determine protection, two 0,25 ml doses of each 
preparation were given to 30 mice subcutaneously on days 
0 and 7. The animals were challenged subcutaneously 14 
days after vaccination-with approximately 2 x 10° CPU. 
Deaths were recorded for 7 days post challenge. Protection 
expressed as no® survivors/total challenged x 100%, 
Table 11. (continued) 
Vaccine Treatment 
Number of CPU 
Admini stered/Animal Protection® 
Soni cated-KCHO 1.5 X lo9 60% 
Sonicated 30,000 g 1.5 z lo9 72^ 
Purified type-specific Undetermined 90^ 
Placebo vaccinates 0$ 
ImmunoKenicity of S, equlsimilis Antigens in 
Comparison of whole cells and sonicated cells 
Swine 
Experiment 1 Eight 3 week old Caesarean derived-
colostrum deprived (CDCD) pigs were allotted to 4 groups 
for comparison of whole cell and sonic derived vaccines. 
Vaccines «ere s;lven Intramuscularly on days 0, 4 and 8 
(Table 12). On day 26, the animals were test bled and 
challenged by intravenous inoculation of S, equlsimili s. 
Elevated temperatures (2 to 4 F) were recorded 24 to 
48 hours postchallenge. Clinical observations ©f laiaeness 
were recorded for 4 days and a lameness index was calculated 
for each group. 
On day 30, all animals were exsanguinated and necrop-
sled. The number of joints with lesions and the number of 
joints containing S. equislmllls are tabulated in Table 12 
M 
along with the lameness Indices, Those animals vaccinated 
with whole cell and sonic vaccines appeared to be protected 
against the challenge while non-vaccinated controls were 
susceptible. 
Serum samples, collected at the time of challenge, 
were analyzed for their S. eqnislmllls antibody content. 
The geometric mean complement-fixation (GM-CP) titer for 
whole cell vaccinates was 80, for sonic vaccinates it was 
240 and for both control groups it was less than 10, 
Experiment 2 Ten 4 week old CDCD pigs were allotted 
to h groups for comparison of whole cell and sonic derived 
vaccines. Vaccines were given intramuscularly on days 0, 
4- and 8 (Table 13), On day 26, all animals were test bled 
and challenged by intravenous inoculation of S, equisimilis. 
All challenged animals had elevated temperatures 
(2 to ^  P) 24 to 72 hours postoballenge. Clinical obser--
Vations of lameness were recorded for 4 days and a lameness 
index was calculated for each group. 
On day 30, all animals were exsanguinated and necrop-
sieds The number of joints with lesions and the number of 
joints with S, equisimilis are tabulated in Table 13 along 
with the lameness indices. Those animals vaccinated with 
streptococcal vaccines appeared to be protected against 
challenge while non-vaccinated controls were susceptible. 
ikz  
Serum samples, collected at the time of challenge» 
were analyzed for their S, equlsimills antibody content. 
The GM-CF titer for whole cell vaccinates was 80, for 
sonic vaccinates it was 320 and for both control groups 
it was less than 10, 
Comparison of hot acid and sonic derived vaccines 
Experiment 3 Nine 3 week old CDCD pigs were allotted 
to 3 groups for comparison of hot acid extract and sonic 
derived vaccines. Vaccines were given intramuscularly 
on days 0, 4 and 8 (Table 14). On day 33, all animals were 
test bled and challenged by intravenous inoculation of S, 
equislmilis. 
Elevated temperatures (1,4 to 3.6 F) were observed 24 
hours postchallenge. Clinical observations ®f lameness 
were recorded for 5 days and a lameness index was calculated 
for each group. 
On day 38, all animals were exsanguinated and necropsied. 
The number of Joints with lesions and the number of joints 
containing S, equislmilis are tabulated in Table 14 along 
with Ismsnsss indices. Both vaccinated groups demonstrated 
similar levels of protection following challenge when com­
pared to the controls. 
Serum samples, collected at the time of challenge, 
were analyzed for their S. equisimilis antibody content. 
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The GM-CP titer for hot acid extract vaccinates was 210, 
for sonic extract vaccinates it was 533 and for the control 
group it was less than 10, 
Evaluation of sonic derived vaccine In swine 
Experiment k Ten 3 week old CDCD pigs were allotted 
to 2 groups for evaluation of 2 doses of sonic derived 
vaccine. The vaccine was given intramuscularly on days 0 
and 8 (Table 15), On day 22 the animals were test bled 
and challenged by intravenous inoculation of S, equisimilis. 
Elevated temperatures (0,6 to 3 F) were observed 24 
to 48 hours postchallenge. Clinical observations of lame­
ness were recorded for 5 days and a lameness index was 
calculated for each group. 
On day 27» all animals were exsanguinated and necrop-
sled. The number of joints with gross lesions and the 
number of joints containing S, equlsimills are tabulated 
in Table 15 along with the lameness indices. The vaccinates 
appeared to be protected against a virulent challenge while 
the non-vaocinates were susceptible. 
Serum samples, collected at the time of challenge; 
were analyzed for their S, equlsimills antibody content 
by complements-fixation « The GM-CF titer for the sonic 
vaccinates was 192 and for the control group it was less 
than 10, 
Table 12. Experiment 1, Immunogenlclty of S, equlslmllls 78-A 
whole cells and sonicated cells In swine, 
Evaluation of Response to Challenge 
No, Joints 
Lameness No. Joints Positive for 
Group No. Pigs Treatment Index® With Lesions" 8. equlsimllis° 
2/24 
0/24 
®Lameness index = Total number of limbs exhibiting lameness during 4 days 
postchallenge divided by total ©baarvations. 
i ^Total number of arthritic joints over total joints observed at necropsy 
4 days postchallenge, 
°Total number of Joints containing S. eguislmilis over total number of 
joints cultured at necropsy 4 days postchallenge. 
^Colonj'- forming units of S. eguislmilis as evaluated by plate count. 
Three 2 ml doses of 0.09 1/24 
whole cells + incom­
plete Preund adju­
vant I.M, challenged 
I.V. with 3.2 X 10® 
CPU-SE*. 
Three 2 ml doses of 0.03 1/24 
sonicate + incomplete 
Preund adjuvant I.M. 
challenged loV. with 
3.2 z 10° CPU-8E. 
Table 12, (continued) 
Group No» Pigs Treatment 
Three 2 mi doses of 
placebo 4- incomplete 
Preund adjuvant :[.M. 
challenged I.V. with 
3.2 X 10° CPU-SS. 
4 2 Not vaccinated 
Not challenged 
Evaluation of Response to Challenge 
No. Joints 
Lameness No. Joints Positive for 
Index^ With Lesions S, equisimills^ 
0.42 13/24 11/24 
0.00 0/24 0/24 
Table 13o Experiment 2, InununogenîLclty of S» equlsimills 78-A3X 
whole cells and sonicated cells in swine. 
Evaluation of Response to Challenge 
Group 
1 
NOo Pigs 
3 
Treatment 
Lamene s s 
Index® 
Three 2 ml doses whole 0,03 
cells 4- incomplete 
Preund adjuvant XoK, 
challenged I«V, trlth 
2,8 X 10° GFU-SE" 
Tliree 2 ml doses 0,00 
sonicate incom-
plete Preund adju-
Vfânt I «Me challenged 
I.V. with 2.8 z :iOO 
CFU-SE. 
No. Joints 
With Lesions" 
1/36 
1/36 
No, Joints 
Positive for 
So equlsimilis*^ 
0/36 
0/36 
s>Lameness lnde%=Tptal number of limbs exhibiting lemeness during 5 days 
postchallenge divided by total ©Dsarvaïis^s.. 
^Total number of arthritic joints over total joints observed at necropsy 
5 days postchallenge* 
®Total number of joints containing S, equislmilis over total number of 
joints cultured at necropsy 5 days post cTiallenge. 
Colony forming units of S. eguisimilis as evaluated by plate count, 
Table 13» (continued) 
Group No. Pigs 
3 2 
Treatment 
T)iree 2 ml doses 
placebo 4- Incom­
plete Freund adju-
vjant I.Mo challenged 
I. V« with 2.8 X 10° 
CPU-SE. 
4 2 Not vaccinated 
Not challenged 
Evaluation of Response to Challenge 
No. Joints 
Lameness Noe Joints Positive for 
Index® With Lesions° S, equlslmllls^ 
0.^5 10/24 11/24 
0,00 0/24 0/24 
->3 
Table 14, Experiment 3» Immunogenlcity of 8, equlsimilis 78-A3X 
sonicated cells and hot acid extract In swine. 
Group No» Pigs Treatment 
Three 2 ml doses of 
sonicate + Incom­
plete Preund adju-
Vfant loMo challenged 
I.V. with 3.9 3C ;io° 
CPU-SEy. 
Three 2 ml doses of 
hot-add extract + 
incomplete Preund 
adjuvant I«Mo chal­
lenged I>Vo with 
3.9 X 10° CPU-8E. 
Evaluation of Response to Challenge 
No, Joints 
Lameness No. Joints Positive for 
Index^ With Lesions" S, equlsimilis 
0.08 9/36 
0.06 4/36 
4/36 
1/36 
^Lameness lnde:r=Total number of limbs exhibiting lameness during 5 days 
postchallenge divided"by total observations. 
^Total number of arthritic joints over total joints observed at necropsy 
5 days postchallenge. 
°Total number of joints containing S. equlsimilis over total number of 
joints cultured at necropsy 5 days postcRalfenge. 
^Colony forming units of So equlsimilis as evaluated by plate count. 
Table 14. (continued) 
Group No. Pigs 
Evaluation of Response to Challenge 
Treatment 
Lameness 
Index^ 
No, Joints 
With Lesions' 
Tl-iree 2 ml doses of 
placebo 4- incomp].ote 
Freund adjuvant I,Mo 
challenged I,V, with 
3..9 X 10° CPU-SE„ 
0.48 19/36 
Noe Joints 
Positive for 
S, equisimilis* 
11/36 
f-» 
-Pr 
vO 
Table 15» Experiment 4. Immunogenlcity of S, equlsimllls 78-A 
sonicated cells In swine. 
Group No, Pigs Treatment 
Two 2 ml doses of 
sonicate -i- incom­
plete Freunds 1^11, 
challenged I„¥e 
with 7«2 % 10° 
CFU-SEG. 
No t » vac c i nat e d 
challenged IoY« 
with 7.2 X 10° 
CPU-SE/ 
Evaluation of Response to Challenge 
Lameness No, Joints , 
Index®^ 
0.05 
0.25 
With Lesions 
2/60 
15/60 
No, Joints 
Positive for 
S. equislmilis^ 
1/60 
4/60 
^Lameness inde:iC--Total number of limbs exhibiting lameness during 5 days 
postchallesige divided by total obsfjrvatlans. 
^Total number of arthritic joints over total joints observed at necropsy 
5 days postchallengo« 
°Total number of joints containing 8. equisimilis over total number of 
joints cultured at necropsy 5 days postc'Eallerig©, 
^Colony forming? units of S. equisimilis. Challenge material from frozen 
culture, 
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Experiment 5 Sixteen 3 week old naturally farrowed 
pigs were allotted to 2 groups for evaluation of the sonic 
vaccine» The vaccine was given intramuscularly on days 0, 
4 and 8 (Table 16), On day 26, all animals were test bled 
and challenged by intravenous inoculation of S, equlslmllis. 
Elevated temperatures (2 to 3 F) were recorded Zk to 
48 hours post challenge. Clinical ©bservatioas ©f lameness 
were recorded for 5 days and a lameness index was calculated 
for each group. 
On day 31, the animals were exsanguinated and necrop-
sied. The number of joints with gross lesions and the 
number of joints containing Se, equisimilis are tabulated 
in Table 16 along with the lameness indices. 
Serum samples s collected at the time of challenge were 
analyzed for their S, equisimilis antibody titer by com-
plement-fixation. The GM«=CP titer for the sonic vaccinates 
was 192 and for the controls it was less than 10e 
Experiment 6 Nine 8 week old and five 3 week old 
CBCD pigs were allotted to 3 groups for evaluation of sonic 
vaccine In swine of two different The vaccine was 
given intramuscularly on days 0, 4 and 8 (Table i?)# On 
day 26, all animals were test bled and challenged by intra­
venous inoculation of S. equisimilisa 
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Elevated temperatures (2 to 4 P) were observed Zk to 
72 hours postchallenge. Clinical observations of lameness 
were recorded for 4 days and a lameness index was calculated 
for each group. 
On day 30, all animals were exsanguinated and neorop-
sied. The number of Joints with gross lesions and the 
number of joints containing S. equislnilis are tabulated 
in Table 1? along with the lameness indices. No signifi­
cant differences sere observed in the response of the two 
age groups to vaccination or challenge, except for serum 
antibody » 
Serum samples, collected at the time of challenge, 
were analysed for their S. equisiallis antibody content by 
complement-fixation. The GM-CF titer for both ages of 
sonic vaccinates was 160 and for both ©ontrol groups it 
was less than lOt 
Location of protective antigen in whole cells and sonic 
derived vaccines 
Experiment 7 Fifteen 7 week old CDCD pigs ware 
allotted to v gsQUps for GGspsrison of uafracticnated 
and 30,000 g supernatant of sonicated cells. The vaccines 
were given by intramuscular inoculation on days 0, 4 and 
8 (Table 18). On day 26, all animals were test bled and 
challenged by intravenous Inoculation of 8, equlsiallis. 
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Elevated temperatures (3 to 5 F) were recorded 24 to 
72 hours postchallenge. Clinical observations of lameness 
were recorded for 5 days and a lameness index was calculated 
for each group. 
On day 31» all animals were exsanguinated and necrop-
sied. The number of Joints with gross lesions and the 
number of joints containing S, equisiailis are tabulated 
in Table 18 along with the lameness indices. 
Serum samples, collected at the time of challenge, 
were analyzed for their S, equisimilis antibody content 
by complement-fixation» The GM-CP titer for the sonic 
vaccinates was 260, for the supernatant vaccinates it was 
80 and for both control groups it was less than 10, 
Experiment 8 Thirteen 5 week old CDCD pigs were 
allotted to 5 groups for comparison of whole cells, cell 
walls and 30,000 g supernatant of sonicated cells. The 
vaccines were given by intramuscular inoculation on days 
0, 4 and 8 (Table 19). On day 26, all animals were 
test bled and challenged by intravenous inoculation of 
S. eQuisimilis. 
Elevated temperatures (2 to 4 F) were recorded 24 to 
48 hours postchallenge. Clinical observations of lameness 
were recorded for 4 days and a lameness index was calculated 
for each group. 
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On day 30, all animals were ©ssangulnated and neoyop-
sieda The number of joints with gross lesions and the 
number of joints containing S® eqttlsimilis are tabulated 
in Table 19 along with the lameness Indices. 
Senm samples, collected at the time of ehalleage, 
were analyzed for their S, ©quisimilis antibody content 
by Gomplement-fization, The GM»eF titer for whole @@11 
vaccinates was 30, for cell wall vaceinates it was 320, 
for supernatant vaccinates it was 640 and for both control 
groups it was less tham 10« 
Table 16, Experiment 5« Immunogenicity of S, equisimills 78-A3X 
sonic vaccine in naturally farrowed swine. 
Evaluation of Response to Challenge 
Group Mo» Pigs Treatment 
Lameness 
Index^ 
No, Joints , 
With Lesions 
No. Joints 
Positive f 
So equisini 
10 
Three 2 ml doses of O0O3 
sonicate 4- incomplete 
Freund adjuvant ]:„M. 
challenged I.V. with 
2.9 X 10° CPU-SEC-^ 
Three 2 ml doses of 0,03 
placebo + incompl.ete 
Freund adjuvant 
challenged I.V* with 
2.,9 % 10° CPU-SE, 
4/72 1/72 
or 
19/120 3/12C 
^Lameness lnde3C=Total number of limbs exhibiting lameness during 5 days 
postchallenge divided by total observations. 
^Total number of arthritic Joints over total joints observed at necropsy 
5 days postchallenge. 
°Total number of joints containing _S, equisimills over total number of 
joints cultured at necropsy 5 days postchallenge. 
^Colony forming units of S. equisimills as evaluated by plate count. 
Table 17, Sxperlnent 6, Immunogenicity of _8. equlslmllls 78-A3X 
sonic antigen in swine of different ages. 
Evaluation of Response to Challenge 
No. Joints 
No. Age in Lameness No. Joints Positive for 
Group Pigs Weeks Treatment Index®- With Lesions S. equisimilis 
1 3 8 
2 3 
2 3 8  
2 8 
^Lameness index=Total number of limbs exhibiting Isimeness during days post 
challenge divided bj' total observations, 
^Total number of arthritic joints over total joints observed at necropsy 
4 days postchallengis. 
°Total number of joints containing S, equisimilis over total number of Joints 
©ultured at necropsy 4 days postchallenge, 
^Colony forminj; units of S« equisimilis as evaluated by plate count. 
Three 2 ml doses O.O6 3/36 1/36 
of sonicate +• in­
complete Freund 0.04 2/24 1/24 
adjuvant I,K. 
challenged loY® 
with 2.4 X 10° 
CFU-SEO-e 
Three 2 ml doses 0.22 12/36 12/36 
of placebo + in­
complete Preuiid 0,25 6/24 11/24 
adjuvant I.M, 
challenged 
with 2.4 X 100 
CPU-SE. 
Table !?<, (continued) 
No» Age In 
Group Pigs Meeka; Treatment 
8 Not vaccinated 
Not challenged 
Evaluation of Response to Challenge 
No. Joints 
Lameness No» Joints Positive for 
Index® With Lesions" S, equlsimilis^ 
0.00 
0,00 
0/36 
0/12 
0/36 
0/12 
Table 18. Experiment 7, Immunogenic!ty of S» equlsimllis 78-A3X 
sonicated cells and soluble vaccines In swine. 
Group Ho. Pigs 
Evaluation of Response to Challenge 
Treatment 
Lameness 
Index® 
No, Joints 
With Lesions^ 
Three 2 ml doses of 0,19 
sonicate + Incomplete 
Freund adjuvant I.M, 
challenged I.V» with 
2.4 X 10° CPU-SE°:' 
Three 2 ml doses of 0.23 
soluble® + Incomplete 
Freund adjuvant I,M» 
challenged I.V, with 
2.4 X 10® CPU-3E. 
8/36 
10/60 
No. Joints 
Positive for 
S. equlsimllis 
0/36 
5/60 
^Lameness index=Total number of limbs exhibiting lameness during 4 days post 
challenge divided by total observations. 
^Total number of arthiltic joints over total joints observed at necropsy 
4 days postchall©r^:e. 
GTotal number of joints containing So equislmills over total number of joints 
cultured at necropsy 4 days postcfealleng©. 
(^Colony forming units of S. equislmills as evaluated by plate count, 
®Supernatant from 30»000 g centrifugea, sonicated cells. 
Table 18. (continued) 
Group No. Pigs Treatment 
3 5 Three 2 ml doses of 
placebo + Incomplete 
Freund adjuvant I„M« 
challenged I,V. with 
2.4 X 10° 0PU-8E. 
4 2 Nob vaccinated 
Not challenged 
Evaluation of Response to Challenge 
No. Joints 
Lameness No. Joints ^ Positive for 
Index^ With Lesions S. equisimilis^ 
0.48 28/60 29/60 
0.00 0/24 0/24 M-
% 
Table 19» Experiment 8. Immunogeniclty of _S, equisimllis 78-A3X 
whole cells cell wall and soluble"Vacclnes in swine. 
Evaluation of Response to Challenge 
Group No. Pigs Treatment 
Lameness 
Index® 
Three 2 ml doses of 0*31 
whole cell + incom­
plete Preund adju­
vant I.M, challenged 
I.V. with 2.5 X 10° 
ŒU-SE^e 
Three 2 ml doses of 0.21 
cell wall + incom­
plete Preijnd adju-
viant I.M. challenged 
I.V. with 2.5 X loG 
ŒU-8E. 
No. Joints 
With Lesionsr" 
11/36 
7/36 
No. Joints 
Positive for 
S, equisimllis 
7/36 
5/36 ON 
o 
^Lameness inde%=Total number of limbs exhibiting Isuneness during 4 days post 
challenge divided by total observations. 
^Total number of arthritic joints over total joints observed at necropsy 
4 days postchallenge. 
®Total number of joints containing S. equisimllis over total number of 
joints cultured at necropsy 4 days post cTialTeng©, 
dColony forming: units of S« equisimllis as evaluated by plate count. 
Table 19 « (continued) 
Evaluation of Response to Challenge 
Group No « Pigs 
3 
2 
Treatment 
Lameness 
Index® 
No9 Joints 
With Lesions^ 
No. Joints 
Positive for 
S, equisimllis° 
Three 2 ml doses of 0.15 
soluble® 4 incomplete 
Freund adjuvant I«M, 
challenged I.V, with 
2.5 % 10° CPU-8E, 
Tî'iree 2 ml doses of 0*16 
placebo 4- incomplete 
Freund adjuvajit I„M. 
challenged I.V, with 
2,5 % 10° CPU-SE, 
Not vaccinated 
Not challenged 0,00 
5/36 
13/24 
0/24 
2/36 
16/24 
0/24 
^Supernatant from 30,000 g centrifuged sonicated cells. 
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DISCUSSION 
Two major advances In streptococcosis have resulted 
from this study s a serological test has been developed for 
use in evaluation of the streptococcal antibody response 
in swine and it has been demonstrated that protection 
against S, equisimilis results in swine following intra­
muscular injection of vaccine prepared from the organism. 
During development of the serologic test and the vaccine* 
additional information concerning the antigenic properties 
of S, equisimilis was accumulated. 
The cultural and biochemical characteristics of all 
3. equisimilis strains used in this study were typical for 
the organism (96). All strains were Lancefield Group C 
and fermented trehalose and glycerol but not sorbitol. 
The serotype specificity of both stock and working çTj.ltaires 
was confirmed as reported previously (24$, 246). 
Investigators have demonstrated that antigenicity and 
virulence of Group A streptococci can be enhanced by intra­
peritoneal passage of the cocci through mice (28, 29). This 
treatment generally resulted in an increase in the quantity 
of M-protein present on the cell and an increase in virulence 
for mice. Whether or not the increased M antigen content 
is directly responsible for increased virulence has not 
been established. 
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Virulence and antigenicity of S. equi have been related 
to the presence of an H^proteln-like substance found in the 
capsule (512)0 This substance is directly related to the 
age of the culture. Young cultures commonly contain a 
relatively large capsule with an abundance of the substance, 
while older cultures have lost the majority of this capsule 
and consequently the majority of the M-like substance. 
Utilizing these general concepts, a serotype I strain 
of S. equisimilis was passed 3 times through young pigs. 
The reisolated strain demonstrated an increase in virulence 
for both swine and mice (Tables 2 and 3)» The LD^q 
mice and the arthritic dose 50 for swine were much lower 
for the passaged strain than the parent. The reasons for 
the enhanced virulence were not determined, although 
apparently It was not directly related to antigenicity sino® 
both strains elicited similar levels of streptococcal anti­
body in swine and rabbits. Serial passage of the strain may 
have increased the amount of type-specific antigen and thus 
virulence, or through animal-passage, the strain simply became 
better adapted for swine and mice by slight physical and 
biochemical changes. The capsule of 78=A3X was slightly 
larger than that of the parent strain,1 Regardless of 
. L. Harris, Ames, Iowa. Capsule size. Private 
communication5 1973» 
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the reasons, a 1:100 dilution of a 6 hour broth culture 
consistently induced arthritis In yoking, non-vaccinated 
CDCD swine and death in non-vaoclnated mice. 
In experiment 5» naturally farrowed pigs were challenged 
with 2.9 2 10^ CPU of S, equislmllis according to procedures 
described previously, but they developed less severe arth­
ritis than was commonly observed when CDCD animals were 
challenged. The reason for this difference was not inves­
tigated, However, it is quite possible that the pigs may 
have acquired low levels of antistreptococcal antibodies 
from the sows milk or they may have received a natural 
exposure and developed some protective antibodies. As re­
ported previously (426), S. equislmllis has frequently 
been isolated from the reproductive tract and mammary 
gXânus of SGwS. In order to evaluate atreptooocoal vaccines 
in naturally farrowed pigs, it may be necessary to increase 
the challenge dose. 
Immunity to group A streptococcal infection in man 
has been shown to be at least partially type-specific 
(268), The vitro bactericidal test has been one of the 
most reliable methods for serological assessment of this 
immunity (383), Bactericidal results obtained in prelim­
inary work with So equislmilis and swine serum were difficult 
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to evaluate and Inconsistent5^ thus, other test methods 
were devised to follow the serological response in swine. 
Bone ^  (^3) used crude acid extracts to detect CP 
antibody in serum from glomerulonephritic patients that 
also demonstrated type-specific bacteriostatic activity. 
Recentlys Wittner and Pox (50?) developed a micro-CP test 
for detection of type-specific antibody in serum of 
patients with Group A infection and presented evidence that 
the test could be substituted for- the bactericidal test as 
a measure of protective immunity. Using a highly purified 
hot acid extract, they demonstrated a close correlation 
between CP antibody and bactericidal activity, 
A complement-fixation procedure was developed for use 
in the study of S, equisimilis. The test was utilized in 
comparisons of the serologioal response to various S, equl° 
similis antigens in swine and rabbits (Table 6), The 
application of this procedure for detection of antibodies 
in serum from naturally or experimentally infected swine 
or rabbits has not been completely investigated. The 
results obtained using crude and type-specific antigen "were 
encouraging» although no direct correlation was established 
between the level of humoral antibody and protection. 
^D. L, Harris, Ames, Iowa, Bactericidal testing. 
Private communication, 1972, 
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In the initial work, crude hot acid and sonicated 
whole cell extracts were used in CP and IHA procedures to 
demonstrate a serological response in vaccinated swine 
and rabbits. Because of an apparent lack of specificity, 
it was necessary to purify the antigens. Following puri­
fication of the preparations, it appeared that the princi­
pal antigens in the crude extracts involved in the CP test 
were identical to the type-specific antigen. Evaluations 
of the role of purified type-specific antigen in IHA were 
not done. 
Evidence has been presented that sonic disruption of 
streptococcal cells results in liberation of streptococcal 
M-protein in a more natural form (35) than is obtained with 
hot acid extraction. The native protein is apparently 
hydrolyzed during the acid extraction procedure resulting 
in alteration of its physicochemical form and antigenicity. 
Extraction under alkaline conditions results in less al­
teration than occurs with the hot acid extraction procedure 
(152)0 Use of these various extraction procedures has 
apparently resulted in comparable yields of type-specific 
antigen from Group A streptococci (35)» However# sonica-
tion of S, equisimilis resulted in a much higher yield of 
antigen active in the CP test than did hot acid extraction 
(Table 8). Possibly the type-specific antigen of S, equi­
similis is partially destroyed under acidic conditions. 
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Purification of type-specific antigen from crude 
sonicate with CMC required a variation in dialysis before 
application of the column. Dialysis against phosphate 
buffered saline containing potassium salts resulted in 
an antigen which became bound to the CMC. Dialysis 
against the PBS with sodium salts produced a sonicate 
antigen that behaved similarly to the hot acid extract, 
although, there still appeared to be some retention of 
antigen» The reason for this variation was not investigated. 
Analysis by ID revealed no difference between the 
SD 30,000 g and SD 3,000 g preparations of crude sonicate; 
both preparations contained the group and type-specific 
components (Figure 2), Evidence obtained by starch block 
electrophoresis and molecular sieving Indicated that the 
type-specific component in crude sonicate was not of a 
single species, but rather a composite with different den­
sities and molecular weights all of which appeared to react 
similarly with the type specific antiserum. The ID patterns 
suggest this antigen may have a multiple molecular structure 
similar to the type-specific antigen found in Group A 
(150)» Using a combination of differential centrifugation* 
ammonium sulfate precipitation and ion-exchange chromatog­
raphy, it was possible to obtain from either hot acid 
extracts or crude sonicate a preparation that contained a 
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single band detectable by Immunodiffusion (Figure 9)* 
Electrophoresis of this preparation in acrylamide gel 
revealed two bands. 
As indicated in Table 5e som® evidence of serotype 
specificity was noted in hyperimmune rabbit serums by CP 
with crude sonicate or hot acid extracts as antigens. 
There were numerous cross reactions between the various 
serotypes when non-absorbed antiserums were used. These 
cross reactions may be attributed to the variety of anti­
genic components present on or in the whole cells used 
during the rabbit immunization procedures. Specificity 
of the type-specific antigen was evaluated using rabbit 
antiserum against all four known swine serotypes. As 
indicated in Figure 9, the only visible band was observed 
between type-specific antigen and its homologous antiserum 
whereas crude preparations contained at least 3 separate 
antigens (Figure 8), Serological specificity of the type-
specific antigen was evaluated by use of the CP test. 
Table 7 presents a comparison of crude hot acid extract 
and purified antigen evaluated against the same four sero­
types, Using crude antigen, a 4 fold difference was detected 
between the two serotypes (Table 5)« whereas type-specific 
antigen demonstrated a strong homologous reaction but 
failed to detect any complement-fixing antibodies in 
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heterologous antiserum (Table 7). Thus, from the original 
crude hot acid or sonic extracts, an antigen was separated 
which reacted with its homologous serotype in complement-
fixation and ID procedures; however» the antigen did not 
react with either type-specific or non-adsorbed serum from 
heterologous serotypes of So equisimills suggesting that 
it was type-specific. It appears that the CP test is 
primarily detecting type-specific antibody with homologous 
antiserum» 
Fractionation of serum from vaccinated swine and 
rabbits by chromatography on Sephadex G-200 revealed that 
the serums contained the usual protein components. Sero­
logical evaluation of pooled samples of peak 1 (IgM) and 
peak 2 (IgG) demonstrated that antibodies against S, equi-
slmllis were present in both fractions (Table 10)j a situ­
ation analogous to findings reported for immune Group A 
serum (517). Most of the IHA activity of swine serum was 
present in the IgM fraction, whereas the IgG fraction 
contained most of the CP activity® These findings are 
eonsistent with previous reports concerning the activity 
of these two immunoglobulin classes» No attempts were made 
to determine the role of antibodies in the two immunoglob­
ulin classes in protection. 
The type-specific component was not separated from the 
group polysaccharide by starch block electrophoresis 
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(Pltçure 3) • Protection tests In mice Indicated that the 
protective antigen was concentrated near the point of 
application (Figure 3) and that It was associated with 
samples containing type-specific antigen. As listed in 
J^able^L^^g'otiBcjilQn was observed in some vaccinated mice 
that did not receive type-specific antigen, although this 
test was not confirmed. However, protection tests using 
purified type-specific antigen confirmed the protective 
effect of type-specific antigen in mice (Table 11). This 
antigen was not evaluated in swine. 
S. equisimills has been reported to be a very poor 
immunity producer, as are most streptococci (11^, 492), 
Adjuvants have been used with many different antigens to 
improve their Immunogenlclty and consequently an adjuvant 
was used in this study. Incomplete Preund mineral oil 
adjuvant was selected because it produces an optimum effect 
(159, 510). However, this type of adjuvant could not be 
utilized in animals used for human food, consequently 
another adjuvant would be required. There are several 
commercially available adjuvants that could be evaluated. 
Possibly, the streptococcal antigen could be Incorporated 
into one of the presently licensed swine mixed bacterlns. 
171 
The use of whole cell vaccines for control of strep­
tococcal infection in man and animals has been reported 
previously (22, 15^), In animals, immunogenicity appears 
to be related directly to the animal used and not to the 
bacterin preparation. Bazeley reported that vaccination 
of equine foals with heat-killed, young cultures of S, egul 
induced a protective antibody response similar to that 
conferred by recovery from the natural disease (22)» 
In bovine streptococcal mastitis, there is no prepa­
ration effective in producing complete immunity against 
8. agalactlae, Lancefleld and Frelmer (279) discussed two 
type-specific antigens that they felt were related to pro­
tection* although animals vaccinated with these antigens 
were not protected against an experimental challenge» Con­
siderable progress has been made recently in immunity to 
streptococcal mastitis by the adaption of a passive mouse 
protection test for the assay of protective antibodies in 
bovine milk and serum (336). With this test it is possible 
to compare in the bovine, the results of vaccination with 
certain antigenic preparations, as well as the effect of 
the route of inoculation and the duration of immunity. 
1 2 
Norcross (335) reported that inoculation of 1 % 10 for­
malin inactivated whole cells in the area of the supra-
mammary lymph nodes elicited milk antibodies of the 
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immunoglobulin classes IgM, IgG and IgA. The IgG antibody 
has been shown to be protective and probably functions at 
the site of infection to reduce infection and inflammation. 
Norcross has vaccinated a cow with a polyvalent bacterin 
which contained all 5 type-specific antigens, and demon­
strated by use of the passive mouse protection test that 
the animal produced circulating protective antibodies to 
each type. The duration of the heightened resistance was 
not established» 
In swine, whole cell bacterins have been used in 
attempts to control streptococcal lymphadenitis (SLS), 
uterine infections and deaths attributed to beta-hemolytic 
streptococci (195, 200, 429), None of the bacterins used 
to control SLS were able to significantly reduce the prev­
alence of the disease and consequently a living avirulent 
strain was developed to control SLS, In the case of the 
other two diseases, the whole cell bacterins were reported 
to be much more successful. One of the basic reasons 
for the success appeared to be related to repeated inocula­
tions of the bactsrins. 
In view of the success of streptococcal whole cell 
bacterins in the control of equine strangles and beta 
hemolytic streptococcal infections in swine, attempts to 
develop a S, equlsimllls whole cell bacterin were initiated. 
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Evidence from mouse protection tests indicated that the 
protective effect was not related to the inactivating agent 
(Table 11). Thus, a formalin inactivated culture, which 
was mixed with incomplete Freund adjuvant, was inoculated 
intramuscularly into s^ine in 2 doses in an attempt to 
modify or prevent an artificially Induced So equisimilis 
infection. Following challenge, no protection was deaon« 
strated in the vaccinates when compared to the response 
of non-va coins ted oont-rolSo 
Swine receiving 2 doses of whole cell vaccine commonly 
failed to develop sufficient antibody to afford protection 
against challenge » The need for multiple injections of 
streptococcal cells or their components to produce high 
titer antibodies in man and animals has been demonstrated 
(15^» 295). Bazelej (22) and Engelbrecht (1)%) found that 
3 doses of S, equi vaccine were necessary before complete 
immunity developed in horses. Similar results have been 
obtained during vaccination attempts in humans with Group A 
streptococcal extracts, fere et al. (195) used 6 doses of 
whole sell bastsrin tc control dsat-h« attributed to beta 
hemolytic streptococci. 
In the present study, a sequential rise in the anti­
body titer occurred following multiple streptococcal 
injections. In experiment 1, the animals were vaccinated 
with three doses of either whole cell or sonic vaccine. 
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Animals that received whole cell vaccine developed low 
levels of CP streptococcal antibody in their serums» 
Following challenge, the vaccinates had less clinical lame- > 
ness and fewer joints with lesions and S, equisimllls than 
non-vaccinated controls. However, animals that received 
sonic vaccine had even higher levels of streptococcal 
antibody and less clinical lameness, joints lesions and 
joints with S, equisimllls than did the whole cell vaccinates. 
Although a low level of protection was induced in swine 
by the whole cell vaccine» greater protection was Induced 
by the sonic vaccine. 
Shortly after completion of experiment 1, biochemical 
and serological evaluations of the swine passaged strain 
78-A3X, were completed. This strain was used ina protec­
tive challenge experiment conducted according to protocol 
of experiment 1. Following challenge, the elliilcal picture 
and necropsy results were similar to those observed in 
experiment 1. Again, the sonic vaccinates appeared to 
have higher levels of serum antibody and were more re­
sistant to challenge. 
Results obtained in this study with whole cell vaccines 
are similar to those obtained in experimental trials in 
humans with whole cell bactsrlns. No specific reasons 
have been given for the failure of whole cell vaccines 
to protect humans, although, one of the predominant reasons 
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appears to be that the type-specific antigen Is only a 
minor cellular component of the total antigenic complex 
and antibodies against it are either blocked or slow in 
being produced. It is quite possible that an analogous 
situation may exist with 8, equisimilis since the type-
specific antigen is also related to the cell wall (246). 
Group A whole cell vaccines frequently result in the 
appearance of untoward reactions in the human vaccineèSe 
No such reactions were noted in any of the swine vaccinated 
with 2 or 3 doses of S. equisimilis whole cell vaccine. 
Antigen extracted from Group A streptococcal cells 
by the hot acid method is the most commonly used material 
for experimental human streptococcal vaccine (153), Highly 
purified hot acid extracted M-protein preparations, precip­
itated with alum and given in a minimum of 3 subcutaneous 
inoculations 4 weeks apart to human volunteers, induces 
type-specific antibody in about 75 per cent of vaccinées 
(15^). A protective test in humans indicated that purified 
M-protein induced type-specific antl-M»antibodles that 
were able to afford the vaccinsss some clinical protection 
against virulent challenge. 
Experiment 3 was designed to evaluate hot acid extract 
as a potential vaccine for swine and confirm the protec­
tive effect induced by a sonic vaccine» The hot acid 
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extract was prepared according to methods developed for 
Group A vaccine (1^4) except it was not purified by CMC, 
No untoward reactions were observed in any of the vaccinates 
before challenge and serological evaluations demonstrated 
relatively high GM-CP titers. Following challenge, pro­
tective antibodies were present in vaccinated swine as 
compared to the response of non-vaccinates. Sonic vacci­
nates in this trial appeared to have protective levels 
similar to the hot acid extract vaccinates. Since 3 doses 
of sonic vaccine appeared to elicit similar protection, 
it was decided to pursue this type of vaccine. 
Alkaline extracts of S, equisimilis were evaluated in 
the mouse protection test (Table 11) and ^5 per cent of the 
mice vaccinated with 2 doses failed to survive challenge» 
The material was never used in swine as a vaccine because 
of its low protective effect in mice and it has never been 
used in human vaccine trials. Of course, mouse protection 
tests may or may not be a reliable indicator of potential 
for use in swine. Nevertheless, the mouse test was used 
in this work to give some preliminary evidence of protec­
tive immunogenicity, If any antigen elicited relatively 
high levels of protection in mice, the material was used 
to vaccinate swine in a protective challenge study. Whole 
cell vaccines were less efficacious in mice as well as 
in swine. 
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Sonio vibration was found to be an effective means of 
releasing a variety of antigenic components from S. equi-
similis. This method disrupted approximately 100 per cent 
of the cells as determined by microscopic and cultural 
examinations» Sonicated fractions proved to be antigenic 
in vivo and ^  vitro. Chemical fractionation of bacteria, 
such as acid extractionsp has a tendency to destroy Important 
antigens while sonication apparently does not produce a 
similar effect. 
During development of the CP test it was demonstrated 
that sonic released antigen was more potent as a CP antigen 
than hot acid extract on a per cell basis (Table 7)» Besdin® 
and Pine (35) reported sonic vibration of heat killed group 
A streptococci released high molecular weight M-antlgen® 
They reported that sonicated whole cell extract had compo-
ents by ID: a high molecular weight M-antigen, the group 
polysaccharide» T antigen and another unidentified antigen» 
They concluded that this preparation was mors antigenic 
than the low wight material, although as mentioned previously, 
this preparation has not been used in human vaccins trial®» 
In experiment ^ lEsaunogenicity of two doses of S. equi-
slmllls 78-Â sonicate for swine was evaluated. Following 
challenge with a frozen culture, the sonio vaccinates dem­
onstrated protection against challenge. Feu isolates of 
So eoulsimllls were made in either group. It appeared that 
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2 doses of sonic vaccin© were able to elicit protective 
antibodies Ir this ezperlaent as evaluated by challenge with 
culture that had been frozen. This study was not repeated 
with the swine passed strain or with a fresh challenge® 
This is an area that needs to be investigated further. Use 
of the frozen challenge appeared to be less severe that that 
observed In challenge experiments where s^ine«passaged or 
fresh culture were used. 
In experiment 5 immunogenloity of sonic vaccine in 
naturally farrowed animals was evaluated. The vaccine 
induced CF s^rum antibody levels comparable to that in 
CDCD swine. However, it Is not possible to draw any firm 
conclusions based on this challenge study. Both vaccinates 
and controls developed a less severe arthritis than was 
commonly observed %hen CDCD snisssls were ohall@ng@d. The 
arthritic dose 50 of S, eoulslEllls and the immunogenlclty 
of sonic extract for naturally farrowed swine should be 
determined. Obviously, a vaccine would be used primarily 
in naturally farrowed swine in the field, 
Results of experiment 6 indicated that 3 and 5 week 
old swine responded similarly to 78°A3X sonic vaccine. 
Following challenge, no appreciable differences were observed 
between the 2 groups. Protection was observed in the sonic 
vaccinates but not in controls «, 
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In experiments 7 and 8 attempts were Initiated to 
determine the location of the protQctive antigan in crude 
preparations. Relatively high GM=CP titers were demonstrated 
in swine vaccinated with sonic and soluble vaccines while 
the whole cell vaccinates were low. Greater protection 
occurred in animals that received soluble or particulate 
vaccines than those animals that received the whole cell 
or placebo vaccine. A severe response to challenge occurred 
in these tests. Clinical observations of lameness were 
almost identical for vaccinates and controls, although 
other parameters indicated limited protection occurred in 
most vaccinates. Based on these 2 experiments and the 
mosue test, evidence was suggestive, not not conclusive, 
that the protective antigen was associated with the soluble 
coiaponsr.ts. Evidence obtained from the mo%ae protection 
tests indicated that the type-specific antigen was related 
to protection. 
Experimental findings indicated that sonic derived 
8. equisimills vaccine was Immunogenic in swine from 3 to 8 
weeks of age as evidenced by the induction of high levels 
of circulating CP antibodies following 3 intramuscular 
injections of the vaccines There appears to be a correla­
tion between the presence of these antibodies and protection 
since most of those animals demonstrating high CF antibody 
levels failed to develop clinical and necropsy evldenee 
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of arthritis following challenge. However, the vaccin© was 
not 100 per cent effective since vaccinates occasionally 
had symptoms of arthritis following challenge. The CP 
test was useful for determining the immune status of groups 
of swine but correlated poorly with the degree of protection 
in individual animals, 
Passive Immunity has been used in studies related to 
Group Â organisms. Serums taken from adult swine or pigs 
5 weeks after an experimental inoculation with a Group D 
strain (5» 6) prevented infection by a homologous strain. 
Administration of serum taken from swine hyperlmmunlzed 
against S, equisimills to susceptible baby pigs failed to 
protect them against a challenge dose of S. equisimilis. 
Challenge studies were not encouraging and this method of 
i 
investigation was not pursued," 
Evidence was obtained that colostral antibody agair-st 
S. equisiailis could be induced in sows which would protect 
baby pigs against a challenge dose of 8, eauisimllls,^ 
Administration of 2 or 3 doses of S, eQUisimllis sonic 
vaccina, by intramuscular or intramammary routes, resulted 
D. Woods, Ames, Iowa, Unpublished, 197^* 
^D, L, Harris, Ames, Iowa, Colostral antibodies. 
Private oommunlcatlon, 1973® 
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In 2 to 8 fold Increases In serum streptococcal antibody 
titers. Some evidence of protection (reduced clinical 
lameness, joint lesions and Joints containing S, equislmills) 
was detected in pigs nursing vaccinated soiss, Colostral 
protection appeared to be better when sows were vaccinated 
with sonic vaccine combined with incomplete Freund adjuvant. 
In comparing whole cells, hot acid and sonic derived 
extracts as potential vaccines, crude sonic extract In 
combinntion with an adjuvant, appears to be the best over­
all preparation for use in swine. Whole cell bacterins 
simply were not immunogenic enough to protect large numbers 
of animals. Hot acid extracts appeared to be relatively 
Immunogenic, but a relatively large volume of cells was 
required in order to produce any quantity of vaccine and 
the cost could be prohibitive. The sonic extract thus 
appears to be the most psactieal matazlal. The major dis­
advantage with this type of vaccine is that incomplete 
cell disruption followed by low speed centrifugatlon may 
leave viable organisms in the vaccine and these then could 
be inoculated into susceptible animals with the possibility 
of spreading the disease, although this problem would be 
eliminated by the addition of a chemical preservative to 
the vaccine before it is used in the field. Crude prepara­
tions of streptococcal cells have been shown to contain a 
wide variety of antigens, some of which are detrimental 
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in humans. Because Group A and Group C cells have similar 
properties, it is quit® possible that an analogous situation 
may exist #lth S. equisimilis. Thus, the us® of purified 
antigens would eliminate many of the possible undesirable 
factors associated with relatively crude preparations. 
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